2025-08-20 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
29,192,181 |
754,867 |
|
|
|
2025-08-15 |
13G/A
|
DNMRQ / Danimer Scientific, Inc.
|
|
89,999 |
6,200,000 |
|
|
|
2025-08-15 |
13G/A
|
KANT / Kineta, Inc.
|
|
1,366,816 |
1,823,138 |
|
|
|
2025-08-15 |
13G/A
|
RANI / Rani Therapeutics Holdings, Inc.
|
|
2,574,000 |
6,260,000 |
|
|
|
2025-08-15 |
13G/A
|
BKYI / BIO-key International, Inc.
|
|
359,703 |
359,703 |
|
|
|
2025-08-15 |
13G/A
|
REKR / Rekor Systems, Inc.
|
|
2,850,000 |
2,473,801 |
|
|
|
2025-08-15 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
1,501,625 |
16,150,000 |
|
|
|
2025-08-15 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
2,334,826 |
4,812,000 |
|
|
|
2025-08-15 |
13G/A
|
RMTI / Rockwell Medical, Inc.
|
|
2,149,471 |
8,876,000 |
|
|
|
2025-08-15 |
13G/A
|
PDSB / PDS Biotechnology Corporation
|
|
2,283,288 |
2,812,000 |
|
|
|
2025-08-15 |
13G/A
|
BCTX / BriaCell Therapeutics Corp.
|
|
|
336,000 |
|
|
|
2025-08-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
6,572,000 |
4,735,464 |
|
|
|
2025-08-14 |
13G/A
|
VNRX / VolitionRx Limited
|
|
9,804,352 |
9,804,352 |
|
|
|
2025-08-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
9,235,571 |
9,235,571 |
|
|
|
2025-08-14 |
13G/A
|
SCLX / Scilex Holding Company
|
|
|
4,800,000 |
|
|
|
2025-08-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
316,084 |
289,876 |
|
|
|
2025-08-14 |
13G/A
|
|
|
|
1,287,337 |
|
|
|
2025-08-14 |
13G/A
|
OTRK / Ontrak, Inc.
|
|
629,825 |
400,000 |
|
|
|
2025-08-14 |
13G/A
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
5,096,251 |
5,096,251 |
|
|
|
2025-08-14 |
13G
|
IMUX / Immunic, Inc.
|
|
|
428,543 |
|
|
|
2025-08-14 |
13G/A
|
ANRO / Alto Neuroscience, Inc.
|
|
1,600,000 |
1,996,000 |
|
|
|
2025-08-14 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
2,094,000 |
1,624,000 |
|
|
|
2025-08-14 |
13G
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
5,096,251 |
703,557 |
|
|
|
2025-08-14 |
13G/A
|
ALUR / Allurion Technologies Inc.
|
|
391,643 |
185,000 |
|
|
|
2025-08-14 |
13G/A
|
|
|
|
1,600,000 |
|
|
|
2025-08-14 |
13G/A
|
NVRO / Nevro Corp.
|
|
3,736,000 |
689,642 |
|
|
|
2025-08-14 |
13G/A
|
CYCC / Bio Green Med Solution, Inc.
|
|
|
0 |
|
|
|
2025-08-14 |
13G/A
|
PCSA / Processa Pharmaceuticals, Inc.
|
|
578,605 |
2,644,376 |
|
|
|
2025-08-14 |
13G/A
|
GROM / Grom Social Enterprises, Inc.
|
|
|
2,978,000 |
|
|
|
2025-08-14 |
13G/A
|
SPCB / SuperCom Ltd.
|
|
441,692 |
215,435 |
|
|
|
2025-08-14 |
13G/A
|
FGEN / FibroGen, Inc.
|
|
8,500,000 |
723,092 |
|
|
|
2025-08-14 |
13G/A
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
2,996,732 |
1,613,560 |
|
|
|
2025-08-14 |
13G/A
|
ZVSA / ZyVersa Therapeutics, Inc.
|
|
285,037 |
416,800 |
|
|
|
2025-08-14 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
997,004 |
5,960,000 |
|
|
|
2025-08-14 |
13G/A
|
|
|
|
54,042 |
|
|
|
2025-08-14 |
13G/A
|
DTST / Data Storage Corporation
|
|
|
525,583 |
|
|
|
2025-08-14 |
13G/A
|
VTAK / Catheter Precision, Inc.
|
|
1,000,849 |
1,120,635 |
|
|
|
2025-08-14 |
13G/A
|
STKH / Steakholder Foods Ltd. - Depositary Receipt (Common Stock)
|
|
293,941 |
106,596 |
|
|
|
2025-08-14 |
13G/A
|
CYTOF / Altamira Therapeutics Ltd.
|
|
473,870 |
228,584 |
|
|
|
2025-08-14 |
13G/A
|
SHPH / Shuttle Pharmaceuticals Holdings, Inc.
|
|
444,635 |
56,237 |
|
|
|
2025-08-14 |
13G/A
|
OXBR / Oxbridge Re Holdings Limited
|
|
622,165 |
395,792 |
|
|
|
2025-08-14 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
1,313,348 |
2,675,610 |
|
|
|
2025-08-14 |
13G/A
|
SDST / Stardust Power Inc.
|
|
4,526,000 |
4,435,245 |
|
|
|
2025-08-14 |
13G/A
|
MURA / Mural Oncology plc
|
|
1,722,000 |
0 |
|
|
|
2025-08-14 |
13G/A
|
MTVA / MetaVia Inc.
|
|
902,248 |
1,270,887 |
|
|
|
2025-08-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,672,000 |
2,284,381 |
|
|
|
2025-08-14 |
13G/A
|
MDCX / Medicus Pharma Ltd.
|
|
1,266,000 |
935,724 |
|
|
|
2025-08-14 |
13G/A
|
MBRX / Moleculin Biotech, Inc.
|
|
1,250,000 |
1,586,521 |
|
|
|
2025-08-14 |
13G/A
|
KAPA / Kairos Pharma, Ltd.
|
|
1,696,924 |
884,938 |
|
|
|
2025-08-14 |
13G/A
|
INTS / Intensity Therapeutics, Inc.
|
|
872,547 |
1,237,113 |
|
|
|
2025-08-14 |
13G/A
|
ICU / SeaStar Medical Holding Corporation
|
|
1,019,958 |
1,466,096 |
|
|
|
2025-08-14 |
13G
|
ANY / Sphere 3D Corp.
|
|
2,660,745 |
672,134 |
|
|
|
2025-08-14 |
13G/A
|
HSDT / Helius Medical Technologies, Inc.
|
|
|
180,028 |
|
|
|
2025-08-14 |
13G/A
|
COSM / Cosmos Health Inc.
|
|
1,917,710 |
1,582,313 |
|
|
|
2025-08-14 |
13G/A
|
|
|
|
117,368 |
|
|
|
2025-08-14 |
13G/A
|
ENLV / Enlivex Therapeutics Ltd.
|
|
1,781,931 |
209,340 |
|
|
|
2025-08-14 |
13G/A
|
CERO / CERo Therapeutics Holdings, Inc.
|
|
584,548 |
63,308 |
|
|
|
2025-08-14 |
13G/A
|
CELZ / Creative Medical Technology Holdings, Inc.
|
|
148,000 |
135,531 |
|
|
|
2025-08-14 |
13G
|
LMFA / LM Funding America, Inc.
|
|
535,339 |
4,312,354 |
|
|
|
2025-08-14 |
13G
|
RMTI / Rockwell Medical, Inc.
|
|
3,284,144 |
2,149,471 |
|
|
|
2025-08-14 |
13G/A
|
CBUS / Cibus, Inc.
|
|
1,948,000 |
2,540,536 |
|
|
|
2025-08-14 |
13G
|
OPTN / OptiNose, Inc.
|
|
|
29,192,181 |
|
|
|
2025-08-14 |
13G/A
|
BKYI / BIO-key International, Inc.
|
|
596,401 |
359,703 |
|
|
|
2025-08-14 |
13G
|
BPTH / Bio-Path Holdings, Inc.
|
|
436,337 |
561,148 |
|
|
|
2025-08-14 |
13G/A
|
ANGO / AngioDynamics, Inc.
|
|
2,094,000 |
1,527,815 |
|
|
|
2025-08-14 |
13G
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
1,313,348 |
1,188,101 |
|
|
|
2025-08-14 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
411,523 |
260,166 |
|
|
|
2025-08-14 |
13G
|
BITF / Bitfarms Ltd.
|
|
|
1,078,459 |
|
|
|
2025-08-14 |
13G/A
|
PDSB / PDS Biotechnology Corporation
|
|
4,547,925 |
2,283,288 |
|
|
|
2025-08-14 |
13G/A
|
IMV / IMV Inc
|
|
963,952 |
478,945 |
|
|
|
2025-08-14 |
13G
|
ANY / Sphere 3D Corp.
|
|
2,660,745 |
4,435,969 |
|
|
|
2025-08-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
3,850,000 |
1,178,389 |
|
|
|
2025-08-14 |
13G
|
ADTX / Aditxt, Inc.
|
|
|
2,917,975 |
|
|
|
2025-05-15 |
13G/A
|
SHPH / Shuttle Pharmaceuticals Holdings, Inc.
|
|
306,057 |
444,635 |
|
|
|
2025-05-15 |
13G/A
|
SNTI / Senti Biosciences, Inc.
|
|
536,010 |
1,439,812 |
|
|
|
2025-05-15 |
13G/A
|
SNAX / Stryve Foods, Inc.
|
|
445,245 |
395,282 |
|
|
|
2025-05-15 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
411,523 |
411,523 |
|
|
|
2025-05-15 |
13G/A
|
PALI / Palisade Bio, Inc.
|
|
285,417 |
471,906 |
|
|
|
2025-05-15 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
6,378,000 |
5,434,843 |
|
|
|
2025-05-15 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
1,152,000 |
1,516,000 |
|
|
|
2025-05-15 |
13G/A
|
MURA / Mural Oncology plc
|
|
1,700,000 |
1,722,000 |
|
|
|
2025-05-15 |
13G/A
|
MYNZ / Mainz Biomed N.V.
|
|
230,967 |
324,821 |
|
|
|
2025-05-15 |
13G/A
|
RMTI / Rockwell Medical, Inc.
|
|
3,249,178 |
3,284,144 |
|
|
|
2025-05-15 |
13G/A
|
OFIX / Orthofix Medical Inc.
|
|
3,000,000 |
2,964,000 |
|
|
|
2025-05-15 |
13G/A
|
MTVA / MetaVia Inc.
|
|
875,401 |
902,248 |
|
|
|
2025-05-15 |
13G/A
|
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
|
|
|
1,081,183 |
|
|
|
2025-05-15 |
13G/A
|
PTNT / Palatin Technologies, Inc.
|
|
1,992,826 |
1,278,054 |
|
|
|
2025-05-15 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
2,509,977 |
2,334,826 |
|
|
|
2025-05-15 |
13G/A
|
FEAM / 5E Advanced Materials, Inc.
|
|
4,006,784 |
1,083,366 |
|
|
|
2025-05-15 |
13G/A
|
IPDN / Professional Diversity Network, Inc.
|
|
1,334,182 |
103,459 |
|
|
|
2025-05-15 |
13G/A
|
MBIO / Mustang Bio, Inc.
|
|
|
129,213 |
|
|
|
2025-05-15 |
13G/A
|
KTTA / Pasithea Therapeutics Corp.
|
|
133,787 |
142,082 |
|
|
|
2025-05-15 |
13G/A
|
EDBL / Edible Garden AG Incorporated
|
|
1,994,837 |
75,458 |
|
|
|
2025-05-15 |
13G/A
|
EVAX / Evaxion A/S - Depositary Receipt (Common Stock)
|
|
|
310,441 |
|
|
|
2025-05-15 |
13G/A
|
|
|
|
102,539 |
|
|
|
2025-05-15 |
13G/A
|
CKPT / Checkpoint Therapeutics, Inc.
|
|
5,216,445 |
4,362,572 |
|
|
|
2025-05-15 |
13G/A
|
DPRO / Draganfly Inc.
|
|
480,794 |
285,072 |
|
|
|
2025-05-15 |
13G/A
|
ALUR / Allurion Technologies Inc.
|
|
251,742 |
391,643 |
|
|
|
2025-05-15 |
13G/A
|
BPTH / Bio-Path Holdings, Inc.
|
|
613,798 |
436,337 |
|
|
|
2025-05-15 |
13G/A
|
BTAI / BioXcel Therapeutics, Inc.
|
|
|
288,131 |
|
|
|
2025-05-15 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
6,276,000 |
6,296,000 |
|
|
|
2025-05-15 |
13G/A
|
MNTS / Momentus Inc.
|
|
179,458 |
500,958 |
|
|
|
2025-05-15 |
13G/A
|
NAOV / NanoVibronix, Inc.
|
|
349,284 |
39,878 |
|
|
|
2025-05-15 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
5,800,000 |
6,572,000 |
|
|
|
2025-05-15 |
13G/A
|
LMFA / LM Funding America, Inc.
|
|
404,151 |
535,339 |
|
|
|
2025-05-15 |
13G/A
|
MBRX / Moleculin Biotech, Inc.
|
|
339,767 |
1,250,000 |
|
|
|
2025-05-15 |
13G/A
|
INTS / Intensity Therapeutics, Inc.
|
|
1,126,868 |
872,547 |
|
|
|
2025-05-15 |
13G
|
SPCB / SuperCom Ltd.
|
|
0 |
441,692 |
|
|
|
2025-05-15 |
13G
|
SQFT / Presidio Property Trust, Inc.
|
|
756,525 |
1,570,923 |
|
|
|
2025-05-15 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
9,468,000 |
13,700,000 |
|
|
|
2025-05-15 |
13G/A
|
FGEN / FibroGen, Inc.
|
|
6,800,000 |
8,500,000 |
|
|
|
2025-05-15 |
13G
|
PDSB / PDS Biotechnology Corporation
|
|
|
4,547,925 |
|
|
|
2025-05-15 |
13G
|
SDST / Stardust Power Inc.
|
|
|
4,526,000 |
|
|
|
2025-05-15 |
13G/A
|
GLBS / Globus Maritime Limited
|
|
1,200,000 |
1,200,000 |
|
|
|
2025-05-15 |
13G/A
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
2,250,021 |
2,996,732 |
|
|
|
2025-05-15 |
13G
|
PCSA / Processa Pharmaceuticals, Inc.
|
|
|
578,605 |
|
|
|
2025-05-15 |
13G/A
|
ENLV / Enlivex Therapeutics Ltd.
|
|
2,208,000 |
1,781,931 |
|
|
|
2025-05-15 |
13G/A
|
DRMA / Dermata Therapeutics, Inc.
|
|
276,422 |
1,065,076 |
|
|
|
2025-05-15 |
13G/A
|
CYCC / Bio Green Med Solution, Inc.
|
|
841,695 |
24,844,725 |
|
|
|
2025-05-15 |
13G
|
OXBR / Oxbridge Re Holdings Limited
|
|
|
622,165 |
|
|
|
2025-05-15 |
13G/A
|
CYTOF / Altamira Therapeutics Ltd.
|
|
478,547 |
473,870 |
|
|
|
2025-05-15 |
13G/A
|
DNMRQ / Danimer Scientific, Inc.
|
|
171,761 |
89,999 |
|
|
|
2025-05-15 |
13G/A
|
COSM / Cosmos Health Inc.
|
|
2,508,013 |
1,917,710 |
|
|
|
2025-05-15 |
13G/A
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
5,096,251 |
5,096,251 |
|
|
|
2025-05-15 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
5,396,000 |
5,436,000 |
|
|
|
2025-05-15 |
13G/A
|
AXDXQ / Accelerate Diagnostics, Inc.
|
|
2,078,000 |
1,879,227 |
|
|
|
2025-05-15 |
13G/A
|
|
|
|
73,342 |
|
|
|
2025-05-15 |
13G/A
|
VTAK / Catheter Precision, Inc.
|
|
874,079 |
1,000,849 |
|
|
|
2025-05-15 |
13G/A
|
ANY / Sphere 3D Corp.
|
|
2,583,718 |
2,660,745 |
|
|
|
2025-05-15 |
13G
|
MDCX / Medicus Pharma Ltd.
|
|
|
1,266,000 |
|
|
|
2025-05-15 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
9,134,817 |
9,235,571 |
|
|
|
2025-05-15 |
13G
|
MKZR / MacKenzie Realty Capital, Inc.
|
|
|
1,579,006 |
|
|
|
2025-05-15 |
13G
|
KAPA / Kairos Pharma, Ltd.
|
|
|
1,696,924 |
|
|
|
2025-05-15 |
13G/A
|
VNRX / VolitionRx Limited
|
|
9,343,265 |
9,804,352 |
|
|
|
2025-05-15 |
13G
|
LICYQ / Li-Cycle Holdings Corp.
|
|
|
4,567,108 |
|
|
|
2025-05-15 |
13G
|
KANT / Kineta, Inc.
|
|
643,978 |
1,366,816 |
|
|
|
2025-05-15 |
13G/A
|
TMCI / Treace Medical Concepts, Inc.
|
|
6,209,000 |
6,211,000 |
|
|
|
2025-05-15 |
13G
|
IVP / Inspire Veterinary Partners, Inc.
|
|
|
212,725 |
|
|
|
2025-05-15 |
13G/A
|
STKH / Steakholder Foods Ltd. - Depositary Receipt (Common Stock)
|
|
346,487 |
293,941 |
|
|
|
2025-05-15 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
4,836,000 |
5,196,000 |
|
|
|
2025-05-15 |
13G
|
ICU / SeaStar Medical Holding Corporation
|
|
|
1,019,958 |
|
|
|
2025-05-15 |
13G
|
GOVX / GeoVax Labs, Inc.
|
|
495,589 |
1,612,729 |
|
|
|
2025-05-15 |
13G
|
HSDT / Helius Medical Technologies, Inc.
|
|
|
871,134 |
|
|
|
2025-05-15 |
13G/A
|
XRTX / XORTX Therapeutics Inc.
|
|
346,807 |
178,031 |
|
|
|
2025-05-15 |
13G
|
CRIS / Curis, Inc.
|
|
|
1,046,489 |
|
|
|
2025-05-15 |
13G
|
CLDI / Calidi Biotherapeutics, Inc.
|
|
|
3,359,661 |
|
|
|
2025-05-15 |
13G
|
CERO / CERo Therapeutics Holdings, Inc.
|
|
|
584,548 |
|
|
|
2025-05-15 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
7,358,000 |
8,872,000 |
|
|
|
2025-05-15 |
13G/A
|
VINC / Vincerx Pharma, Inc.
|
|
|
274,908 |
|
|
|
2025-05-15 |
13G
|
CELZ / Creative Medical Technology Holdings, Inc.
|
|
|
148,000 |
|
|
|
2025-05-15 |
13G/A
|
TOON / Kartoon Studios Inc.
|
|
4,607,156 |
2,294,582 |
|
|
|
2025-05-15 |
13G
|
BKYI / BIO-key International, Inc.
|
|
164,235 |
596,401 |
|
|
|
2025-05-15 |
13G
|
CBUS / Cibus, Inc.
|
|
|
1,948,000 |
|
|
|
2025-05-15 |
13G/A
|
SXTP / 60 Degrees Pharmaceuticals, Inc.
|
|
476,866 |
77,357 |
|
|
|
2025-05-15 |
13G
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
2,672,000 |
|
|
|
2025-05-15 |
13G
|
ZVSA / ZyVersa Therapeutics, Inc.
|
|
|
285,037 |
|
|
|
2025-05-15 |
13G
|
WKSP / Worksport Ltd.
|
|
|
492,232 |
|
|
|
2025-05-15 |
13G
|
BCLI / Brainstorm Cell Therapeutics Inc.
|
|
299,548 |
717,500 |
|
|
|
2025-05-15 |
13G
|
STAA / STAAR Surgical Company
|
|
|
3,000,000 |
|
|
|
2025-05-15 |
13G
|
ANRO / Alto Neuroscience, Inc.
|
|
|
1,600,000 |
|
|
|
2025-05-15 |
13G
|
ANGO / AngioDynamics, Inc.
|
|
|
2,094,000 |
|
|
|
2025-05-15 |
13G
|
AEMD / Aethlon Medical, Inc.
|
|
315,648 |
1,446,074 |
|
|
|
2025-02-14 |
13G/A
|
MNTS / Momentus Inc.
|
|
2,834,671 |
179,458 |
|
|
|
2025-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
6,258,000 |
6,276,000 |
|
|
|
2025-02-14 |
13G/A
|
MBRX / Moleculin Biotech, Inc.
|
|
300,988 |
339,767 |
|
|
|
2025-02-14 |
13G/A
|
KTTA / Pasithea Therapeutics Corp.
|
|
115,880 |
133,787 |
|
|
|
2025-02-14 |
13G/A
|
LMFA / LM Funding America, Inc.
|
|
297,340 |
404,151 |
|
|
|
2025-02-14 |
13G/A
|
FGEN / FibroGen, Inc.
|
|
6,800,000 |
6,800,000 |
|
|
|
2025-02-14 |
13G/A
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
8,200,000 |
9,468,000 |
|
|
|
2025-02-14 |
13G/A
|
FEAM / 5E Advanced Materials, Inc.
|
|
4,980,000 |
4,006,784 |
|
|
|
2025-02-14 |
13G/A
|
EVAX / Evaxion A/S - Depositary Receipt (Common Stock)
|
|
555,277 |
|
|
|
|
2025-02-14 |
13G
|
ANY / Sphere 3D Corp.
|
|
|
2,583,718 |
|
|
|
2025-02-14 |
13G/A
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
2,192,713 |
2,250,021 |
|
|
|
2025-02-14 |
13G/A
|
ENLV / Enlivex Therapeutics Ltd.
|
|
2,175,884 |
2,208,000 |
|
|
|
2025-02-14 |
13G/A
|
DRMA / Dermata Therapeutics, Inc.
|
|
186,211 |
276,422 |
|
|
|
2025-02-14 |
13G/A
|
EDBL / Edible Garden AG Incorporated
|
|
2,052,277 |
1,994,837 |
|
|
|
2025-02-14 |
13G/A
|
CYCC / Bio Green Med Solution, Inc.
|
|
222,655 |
841,695 |
|
|
|
2025-02-14 |
13G/A
|
CYTOF / Altamira Therapeutics Ltd.
|
|
408,110 |
478,547 |
|
|
|
2025-02-14 |
13G/A
|
DNMRQ / Danimer Scientific, Inc.
|
|
12,018,677 |
171,761 |
|
|
|
2025-02-14 |
13G/A
|
COSM / Cosmos Health Inc.
|
|
2,148,188 |
2,508,013 |
|
|
|
2025-02-14 |
13G/A
|
CKPT / Checkpoint Therapeutics, Inc.
|
|
4,573,746 |
5,216,445 |
|
|
|
2025-02-14 |
13G/A
|
ITRM / Iterum Therapeutics plc
|
|
1,340,000 |
1,445,158 |
|
|
|
2025-02-14 |
13G/A
|
IVDA / Iveda Solutions, Inc.
|
|
236,263 |
139,603 |
|
|
|
2025-02-14 |
13G/A
|
GOVX / GeoVax Labs, Inc.
|
|
946,137 |
495,589 |
|
|
|
2025-02-14 |
13G/A
|
IDAI / T Stamp Inc.
|
|
2,023,286 |
|
|
|
|
2025-02-14 |
13G/A
|
IKT / Inhibikase Therapeutics, Inc.
|
|
758,885 |
3,529,006 |
|
|
|
2025-02-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
2,364,000 |
3,137,553 |
|
|
|
2025-02-14 |
13G/A
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
678,530 |
440,422 |
|
|
|
2025-02-14 |
13G/A
|
CLNN / Clene Inc.
|
|
700,000 |
419,101 |
|
|
|
2025-02-14 |
13G/A
|
BNZI / Banzai International, Inc.
|
|
161,030 |
309,096 |
|
|
|
2025-02-14 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
5,800,000 |
|
|
|
2025-02-14 |
13G
|
MBIO / Mustang Bio, Inc.
|
|
1,911,086 |
|
|
|
|
2025-02-14 |
13G
|
IPDN / Professional Diversity Network, Inc.
|
|
|
1,334,182 |
|
|
|
2025-02-14 |
13G
|
GLBS / Globus Maritime Limited
|
|
0 |
1,200,000 |
|
|
|
2025-02-14 |
13G
|
INTS / Intensity Therapeutics, Inc.
|
|
|
1,126,868 |
|
|
|
2025-02-14 |
13G
|
BTAI / BioXcel Therapeutics, Inc.
|
|
|
|
|
|
|
2025-02-14 |
13G
|
DPRO / Draganfly Inc.
|
|
1,595,208 |
480,794 |
|
|
|
2025-02-14 |
13G
|
BPTH / Bio-Path Holdings, Inc.
|
|
151,515 |
613,798 |
|
|
|
2025-02-14 |
13G/A
|
BCLI / Brainstorm Cell Therapeutics Inc.
|
|
8,083,946 |
299,548 |
|
|
|
2025-02-14 |
13G/A
|
BKYI / BIO-key International, Inc.
|
|
250,000 |
164,235 |
|
|
|
2025-02-14 |
13G/A
|
VNRX / VolitionRx Limited
|
|
9,223,380 |
9,343,265 |
|
|
|
2025-02-14 |
13G/A
|
VTAK / Catheter Precision, Inc.
|
|
105,743 |
874,079 |
|
|
|
2025-02-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
5,200,000 |
5,396,000 |
|
|
|
2025-02-14 |
13G/A
|
VINC / Vincerx Pharma, Inc.
|
|
2,993,104 |
|
|
|
|
2025-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
7,648,000 |
7,358,000 |
|
|
|
2025-02-14 |
13G/A
|
SXTP / 60 Degrees Pharmaceuticals, Inc.
|
|
196,263 |
476,866 |
|
|
|
2025-02-14 |
13G/A
|
TMCI / Treace Medical Concepts, Inc.
|
|
6,196,000 |
6,209,000 |
|
|
|
2025-02-14 |
13G/A
|
STKH / Steakholder Foods Ltd. - Depositary Receipt (Common Stock)
|
|
326,893 |
346,487 |
|
|
|
2025-02-14 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
5,096,000 |
4,836,000 |
|
|
|
2025-02-14 |
13G/A
|
RMTI / Rockwell Medical, Inc.
|
|
3,581,525 |
3,249,178 |
|
|
|
2025-02-14 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
411,523 |
411,523 |
|
|
|
2025-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
7,234,898 |
6,378,000 |
|
|
|
2025-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
1,536,000 |
1,152,000 |
|
|
|
2025-02-14 |
13G/A
|
PALI / Palisade Bio, Inc.
|
|
125,692 |
285,417 |
|
|
|
2025-02-14 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
2,670,000 |
2,509,977 |
|
|
|
2025-02-14 |
13G/A
|
ONVO / Organovo Holdings, Inc.
|
|
1,460,051 |
1,700,684 |
|
|
|
2025-02-14 |
13G/A
|
OFIX / Orthofix Medical Inc.
|
|
3,768,000 |
3,000,000 |
|
|
|
2025-02-14 |
13G/A
|
NVRO / Nevro Corp.
|
|
3,728,000 |
3,736,000 |
|
|
|
2025-02-14 |
13G/A
|
NAOV / NanoVibronix, Inc.
|
|
306,619 |
349,284 |
|
|
|
2025-02-14 |
13G/A
|
MURA / Mural Oncology plc
|
|
1,700,000 |
1,700,000 |
|
|
|
2025-02-14 |
13G/A
|
SQFT / Presidio Property Trust, Inc.
|
|
1,612,825 |
756,525 |
|
|
|
2025-02-14 |
13G/A
|
AWHL / Aspira Women's Health Inc.
|
|
1,256,000 |
800,797 |
|
|
|
2025-02-14 |
13G/A
|
AVGR / Avinger, Inc.
|
|
304,011 |
278,769 |
|
|
|
2025-02-14 |
13G/A
|
REKR / Rekor Systems, Inc.
|
|
2,850,000 |
2,850,000 |
|
|
|
2025-02-14 |
13G/A
|
PTIX / Protagenic Therapeutics, Inc.
|
|
240,000 |
240,000 |
|
|
|
2025-02-14 |
13G/A
|
NEUP / Neuphoria Therapeutics Inc.
|
|
|
1,033,796 |
|
|
|
2025-02-14 |
13G
|
XRTX / XORTX Therapeutics Inc.
|
|
169,790 |
346,807 |
|
|
|
2025-02-14 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
8,200,000 |
6,400,000 |
|
|
|
2025-02-14 |
13G
|
WLDS / Wearable Devices Ltd.
|
|
|
366,354 |
|
|
|
2025-02-14 |
13G/A
|
ATXI / Avenue Therapeutics, Inc.
|
|
115,000 |
100,400 |
|
|
|
2025-02-14 |
13G
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
|
9,134,817 |
|
|
|
2025-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
354,000 |
316,084 |
|
|
|
2025-02-14 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
1,955,202 |
1,025,267 |
|
|
|
2025-02-14 |
13G
|
SNAX / Stryve Foods, Inc.
|
|
|
445,245 |
|
|
|
2025-02-14 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
319,756 |
188,438 |
|
|
|
2025-02-14 |
13G
|
SNTI / Senti Biosciences, Inc.
|
|
|
536,010 |
|
|
|
2025-02-14 |
13G
|
TOON / Kartoon Studios Inc.
|
|
|
4,607,156 |
|
|
|
2025-02-14 |
13G
|
SHPH / Shuttle Pharmaceuticals Holdings, Inc.
|
|
|
306,057 |
|
|
|
2025-02-14 |
13G/A
|
AIMI / AIM ImmunoTech Inc.
|
|
4,330,000 |
3,349,740 |
|
|
|
2025-02-14 |
13G
|
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
|
|
|
934,312 |
|
|
|
2025-02-14 |
13G/A
|
AXDXQ / Accelerate Diagnostics, Inc.
|
|
2,400,000 |
2,078,000 |
|
|
|
2025-02-14 |
13G
|
MYNZ / Mainz Biomed N.V.
|
|
|
230,967 |
|
|
|
2025-02-14 |
13G/A
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
5,096,251 |
5,096,251 |
|
|
|
2025-02-14 |
13G
|
PTNT / Palatin Technologies, Inc.
|
|
720,329 |
1,992,826 |
|
|
|
2025-02-14 |
13G/A
|
WKSP / Worksport Ltd.
|
|
3,097,767 |
1,729,909 |
|
|
|
2025-02-14 |
13G
|
MTVA / MetaVia Inc.
|
|
848,000 |
875,401 |
|
|
|
2025-02-14 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
270,000 |
288,552 |
|
|
|
2025-02-14 |
13G/A
|
VCNX / Vaccinex, Inc.
|
|
164,000 |
136,539 |
|
|
|
2025-02-07 |
13G/A
|
ALUR / Allurion Technologies Inc.
|
|
|
251,742 |
|
|
|
2024-11-19 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
607,422 |
411,523 |
|
|
|
2024-11-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
6,864,000 |
7,234,898 |
|
|
|
2024-11-14 |
13G/A
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
|
223,000 |
|
|
|
2024-11-14 |
13G/A
|
OFIX / Orthofix Medical Inc.
|
|
3,600,000 |
3,768,000 |
|
|
|
2024-11-14 |
13G/A
|
REKR / Rekor Systems, Inc.
|
|
7,050,000 |
2,850,000 |
|
|
|
2024-11-14 |
13G/A
|
PTIX / Protagenic Therapeutics, Inc.
|
|
240,000 |
240,000 |
|
|
|
2024-11-14 |
13G/A
|
RMTI / Rockwell Medical, Inc.
|
|
3,380,534 |
3,581,525 |
|
|
|
2024-11-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
17,100,000 |
1,536,000 |
|
|
|
2024-11-14 |
13G/A
|
NVRO / Nevro Corp.
|
|
3,176,000 |
3,728,000 |
|
|
|
2024-11-14 |
13G/A
|
RVPH / Reviva Pharmaceuticals Holdings, Inc.
|
|
1,764,000 |
3,357,953 |
|
|
|
2024-11-14 |
13G/A
|
NAOV / NanoVibronix, Inc.
|
|
227,009 |
306,619 |
|
|
|
2024-11-14 |
13G/A
|
MURA / Mural Oncology plc
|
|
1,658,000 |
1,700,000 |
|
|
|
2024-11-14 |
13G/A
|
SQFT / Presidio Property Trust, Inc.
|
|
1,457,261 |
1,612,825 |
|
|
|
2024-11-14 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
4,115,227 |
607,422 |
|
|
|
2024-11-14 |
13G/A
|
MYSZ / My Size, Inc.
|
|
367,013 |
141,523 |
|
|
|
2024-11-14 |
13G/A
|
MNTS / Momentus Inc.
|
|
492,000 |
2,834,671 |
|
|
|
2024-11-14 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
4,650,000 |
5,096,000 |
|
|
|
2024-11-14 |
13G/A
|
MNTS / Momentus Inc.
|
|
492,000 |
2,834,671 |
|
|
|
2024-11-14 |
13G/A
|
STAF / Staffing 360 Solutions, Inc.
|
|
839,217 |
105,610 |
|
|
|
2024-11-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
7,384,000 |
7,648,000 |
|
|
|
2024-11-14 |
13G/A
|
MBRX / Moleculin Biotech, Inc.
|
|
3,316,221 |
300,988 |
|
|
|
2024-11-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
4,236,000 |
5,200,000 |
|
|
|
2024-11-14 |
13G/A
|
VTAK / Catheter Precision, Inc.
|
|
752,874 |
105,743 |
|
|
|
2024-11-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
4,572,000 |
6,258,000 |
|
|
|
2024-11-14 |
13G/A
|
GOVX / GeoVax Labs, Inc.
|
|
3,111,069 |
946,137 |
|
|
|
2024-11-14 |
13G/A
|
EYEN / Eyenovia, Inc.
|
|
4,378,000 |
8,600,000 |
|
|
|
2024-11-14 |
13G/A
|
DRMA / Dermata Therapeutics, Inc.
|
|
412,111 |
186,211 |
|
|
|
2024-11-14 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
1,078,459 |
1,313,348 |
|
|
|
2024-11-14 |
13G/A
|
BKYI / BIO-key International, Inc.
|
|
121,494 |
250,000 |
|
|
|
2024-11-14 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
7,214,823 |
319,756 |
|
|
|
2024-11-14 |
13G/A
|
WKSP / Worksport Ltd.
|
|
2,065,892 |
3,097,767 |
|
|
|
2024-11-14 |
13G/A
|
IDAI / T Stamp Inc.
|
|
937,189 |
2,023,286 |
|
|
|
2024-11-14 |
13G/A
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
2,442,742 |
2,364,000 |
|
|
|
2024-11-14 |
13G/A
|
FGEN / FibroGen, Inc.
|
|
9,764,000 |
6,800,000 |
|
|
|
2024-11-14 |
13G/A
|
COSM / Cosmos Health Inc.
|
|
1,504,111 |
2,148,188 |
|
|
|
2024-11-14 |
13G/A
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
653,946 |
678,530 |
|
|
|
2024-11-14 |
13G/A
|
CKPT / Checkpoint Therapeutics, Inc.
|
|
2,715,635 |
4,573,746 |
|
|
|
2024-11-14 |
13G/A
|
VVOS / Vivos Therapeutics, Inc.
|
|
175,099 |
250,277 |
|
|
|
2024-11-14 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
9,536,000 |
8,200,000 |
|
|
|
2024-11-14 |
13G/A
|
VRAX / Virax Biolabs Group Limited
|
|
230,145 |
228,042 |
|
|
|
2024-11-14 |
13G/A
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
4,626,190 |
5,096,251 |
|
|
|
2024-11-14 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
3,770,000 |
1,500,063 |
|
|
|
2024-11-14 |
13G/A
|
TRVN / Trevena, Inc.
|
|
1,827,615 |
44,796 |
|
|
|
2024-11-14 |
13G/A
|
ALUR / Allurion Technologies Inc.
|
|
8,078,000 |
7,806,000 |
|
|
|
2024-11-14 |
13G/A
|
SYBX / Synlogic, Inc.
|
|
1,285,542 |
614,288 |
|
|
|
2024-11-14 |
13G/A
|
TCBP / TC Biopharm (Holdings) Plc - Depositary Receipt (Common Stock)
|
|
105,938 |
27,755 |
|
|
|
2024-11-14 |
13G/A
|
SLRX / Salarius Pharmaceuticals, Inc.
|
|
427,350 |
75,690 |
|
|
|
2024-11-14 |
13G/A
|
SPRB / Spruce Biosciences, Inc.
|
|
2,230,000 |
2,169,245 |
|
|
|
2024-11-14 |
13G/A
|
SLGL / Sol-Gel Technologies Ltd.
|
|
2,135,000 |
1,463,104 |
|
|
|
2024-11-14 |
13G/A
|
INM / InMed Pharmaceuticals Inc.
|
|
606,214 |
696,318 |
|
|
|
2024-11-14 |
13G/A
|
SDIG / Stronghold Digital Mining, Inc.
|
|
|
760,664 |
|
|
|
2024-11-14 |
13G/A
|
SBFM / Sunshine Biopharma, Inc.
|
|
2,130,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
SCNI / Scinai Immunotherapeutics Ltd. - Depositary Receipt (Common Stock)
|
|
518,315 |
44,800 |
|
|
|
2024-11-14 |
13G/A
|
PRFX / PainReform Ltd.
|
|
172,957 |
116,935 |
|
|
|
2024-11-14 |
13G/A
|
PRTG / Portage Biotech Inc.
|
|
1,986,155 |
55,081 |
|
|
|
2024-11-14 |
13G/A
|
RELI / Reliance Global Group, Inc.
|
|
395,583 |
0 |
|
|
|
2024-11-14 |
13G/A
|
OTRK / Ontrak, Inc.
|
|
2,886,000 |
629,825 |
|
|
|
2024-11-14 |
13G/A
|
MOTS / Motus GI Holdings, Inc.
|
|
152,450 |
335,549 |
|
|
|
2024-11-14 |
13G/A
|
NCPL / Netcapital Inc.
|
|
|
40,700 |
|
|
|
2024-11-14 |
13G/A
|
LLAP / Terran Orbital Corporation
|
|
16,300,000 |
10,732,912 |
|
|
|
2024-11-14 |
13G/A
|
MBIO / Mustang Bio, Inc.
|
|
974,907 |
1,911,086 |
|
|
|
2024-11-14 |
13G/A
|
KANT / Kineta, Inc.
|
|
1,054,288 |
643,978 |
|
|
|
2024-11-14 |
13G/A
|
KZIA / Kazia Therapeutics Limited - Depositary Receipt (Common Stock)
|
|
2,639,218 |
54,835 |
|
|
|
2024-11-14 |
13G/A
|
LGVN / Longeveron Inc.
|
|
1,836,000 |
676,229 |
|
|
|
2024-11-14 |
13G/A
|
GNLN / Greenlane Holdings, Inc.
|
|
381,044 |
31,786 |
|
|
|
2024-11-14 |
13G/A
|
HEPA / Hepion Pharmaceuticals, Inc.
|
|
418,000 |
304,574 |
|
|
|
2024-11-14 |
13G/A
|
IINN / Inspira Technologies Oxy B.H.N. Ltd.
|
|
1,528,000 |
971,820 |
|
|
|
2024-11-14 |
13G/A
|
GLBS / Globus Maritime Limited
|
|
1,200,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
FREE / Whole Earth Brands, Inc.
|
|
2,150,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ENVB / Enveric Biosciences, Inc.
|
|
273,109 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ERAS / Erasca, Inc.
|
|
8,096,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
5,200,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
DPRO / Draganfly Inc.
|
|
4,938,978 |
1,595,208 |
|
|
|
2024-11-14 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
2,064,000 |
1,000,000 |
|
|
|
2024-11-14 |
13G/A
|
CVKD / Cadrenal Therapeutics, Inc.
|
|
1,399,384 |
78,611 |
|
|
|
2024-11-14 |
13G/A
|
COEP / Coeptis Therapeutics Holdings, Inc.
|
|
3,520,000 |
1,895,470 |
|
|
|
2024-11-14 |
13G/A
|
CNSP / CNS Pharmaceuticals, Inc.
|
|
676,203 |
1,062,287 |
|
|
|
2024-11-14 |
13G/A
|
BSGM / Streamex Corp.
|
|
5,600,000 |
854,951 |
|
|
|
2024-11-14 |
13G/A
|
BODI / The Beachbody Company, Inc.
|
|
401,907 |
219,913 |
|
|
|
2024-11-14 |
13G/A
|
BFRI / Biofrontera Inc.
|
|
168,105 |
291,149 |
|
|
|
2024-11-14 |
13G/A
|
BJDX / Bluejay Diagnostics, Inc.
|
|
194,525 |
347,697 |
|
|
|
2024-11-14 |
13G/A
|
ETHZ / ETHZilla Corporation
|
|
1,112,480 |
53,935 |
|
|
|
2024-11-14 |
13G/A
|
ASNS / Actelis Networks, Inc.
|
|
301,490 |
316,069 |
|
|
|
2024-11-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
5,800,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
AREB / American Rebel Holdings, Inc.
|
|
|
49,058 |
|
|
|
2024-11-14 |
13G/A
|
AQST / Aquestive Therapeutics, Inc.
|
|
3,924,000 |
2,750,000 |
|
|
|
2024-11-14 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
1,731,034 |
818,750 |
|
|
|
2024-11-14 |
13G/A
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
3,524,000 |
2,207,070 |
|
|
|
2024-11-14 |
13G/A
|
ADIL / Adial Pharmaceuticals, Inc.
|
|
166,972 |
336,310 |
|
|
|
2024-11-14 |
13G
|
VNRX / VolitionRx Limited
|
|
|
9,223,380 |
|
|
|
2024-11-14 |
13G
|
WINT / Windtree Therapeutics, Inc.
|
|
|
270,000 |
|
|
|
2024-11-14 |
13G
|
VCNX / Vaccinex, Inc.
|
|
|
164,000 |
|
|
|
2024-11-14 |
13G
|
VINC / Vincerx Pharma, Inc.
|
|
|
2,993,104 |
|
|
|
2024-11-14 |
13G
|
TMCI / Treace Medical Concepts, Inc.
|
|
|
6,196,000 |
|
|
|
2024-11-14 |
13G
|
TTOO / T2 Biosystems, Inc.
|
|
|
1,396,000 |
|
|
|
2024-11-14 |
13G
|
STKH / Steakholder Foods Ltd. - Depositary Receipt (Common Stock)
|
|
|
326,893 |
|
|
|
2024-11-14 |
13G
|
SXTP / 60 Degrees Pharmaceuticals, Inc.
|
|
|
196,263 |
|
|
|
2024-11-14 |
13G
|
TFFP / TFF Pharmaceuticals, Inc.
|
|
|
359,382 |
|
|
|
2024-11-14 |
13G
|
PMN / ProMIS Neurosciences, Inc.
|
|
|
2,670,000 |
|
|
|
2024-11-14 |
13G
|
RANI / Rani Therapeutics Holdings, Inc.
|
|
|
2,574,000 |
|
|
|
2024-11-14 |
13G
|
SGBX / Safe & Green Holdings Corp.
|
|
|
218,287 |
|
|
|
2024-11-14 |
13G
|
ONDS / Ondas Holdings Inc.
|
|
|
4,750,000 |
|
|
|
2024-11-14 |
13G
|
ONVO / Organovo Holdings, Inc.
|
|
|
1,460,051 |
|
|
|
2024-11-14 |
13G
|
PALI / Palisade Bio, Inc.
|
|
486,914 |
125,692 |
|
|
|
2024-11-14 |
13G
|
PIXY / ShiftPixy, Inc.
|
|
488,424 |
772,422 |
|
|
|
2024-11-14 |
13G
|
NLSP / NLS Pharmaceutics AG
|
|
|
129,475 |
|
|
|
2024-11-14 |
13G
|
MTVA / MetaVia Inc.
|
|
|
848,000 |
|
|
|
2024-11-14 |
13G
|
KTTA / Pasithea Therapeutics Corp.
|
|
|
115,880 |
|
|
|
2024-11-14 |
13G
|
LMFA / LM Funding America, Inc.
|
|
|
297,340 |
|
|
|
2024-11-14 |
13G
|
MOBX / Mobix Labs, Inc.
|
|
|
2,336,000 |
|
|
|
2024-11-14 |
13G
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
8,200,000 |
|
|
|
2024-11-14 |
13G
|
ITRM / Iterum Therapeutics plc
|
|
1,114,145 |
1,340,000 |
|
|
|
2024-11-14 |
13G
|
IVDA / Iveda Solutions, Inc.
|
|
|
236,263 |
|
|
|
2024-11-14 |
13G
|
FEAM / 5E Advanced Materials, Inc.
|
|
|
4,980,000 |
|
|
|
2024-11-14 |
13G
|
GXAI / Gaxos.ai Inc.
|
|
|
207,632 |
|
|
|
2024-11-14 |
13G
|
IKT / Inhibikase Therapeutics, Inc.
|
|
|
758,885 |
|
|
|
2024-11-14 |
13G
|
ENLV / Enlivex Therapeutics Ltd.
|
|
|
2,175,884 |
|
|
|
2024-11-14 |
13G
|
EVAX / Evaxion A/S - Depositary Receipt (Common Stock)
|
|
|
555,277 |
|
|
|
2024-11-14 |
13G
|
DNMR / Danimer Scientific, Inc.
|
|
|
12,018,677 |
|
|
|
2024-11-14 |
13G
|
EDBL / Edible Garden AG Incorporated
|
|
|
2,052,277 |
|
|
|
2024-11-14 |
13G
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
398,692 |
2,192,713 |
|
|
|
2024-11-14 |
13G
|
CYTOF / Altamira Therapeutics Ltd.
|
|
|
408,110 |
|
|
|
2024-11-14 |
13G
|
CLNN / Clene Inc.
|
|
|
700,000 |
|
|
|
2024-11-14 |
13G
|
CYCC / Bio Green Med Solution, Inc.
|
|
|
222,655 |
|
|
|
2024-11-14 |
13G
|
BCLI / Brainstorm Cell Therapeutics Inc.
|
|
|
8,083,946 |
|
|
|
2024-11-14 |
13G
|
BNOX / Bionomics Limited - Depositary Receipt (Common Stock)
|
|
|
1,745,541 |
|
|
|
2024-11-14 |
13G
|
BNZI / Banzai International, Inc.
|
|
|
161,030 |
|
|
|
2024-11-14 |
13G
|
AWHL / Aspira Women's Health Inc.
|
|
|
1,256,000 |
|
|
|
2024-11-14 |
13G
|
AXDXQ / Accelerate Diagnostics, Inc.
|
|
|
2,400,000 |
|
|
|
2024-11-14 |
13G
|
AVGR / Avinger, Inc.
|
|
67,226 |
304,011 |
|
|
|
2024-11-14 |
13G
|
AIMI / AIM ImmunoTech Inc.
|
|
|
4,330,000 |
|
|
|
2024-11-14 |
13G
|
APTO / Aptose Biosciences Inc.
|
|
|
1,955,202 |
|
|
|
2024-11-14 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
2,000,000 |
354,000 |
|
|
|
2024-11-14 |
13G
|
ATXI / Avenue Therapeutics, Inc.
|
|
|
115,000 |
|
|
|
2024-08-09 |
13G
|
ALUR / Allurion Technologies Inc.
|
|
|
8,078,000 |
|
|
|
2024-02-14 |
13G
|
VVOS / Vivos Therapeutics, Inc.
|
|
|
175,099 |
|
|
|
2024-02-14 |
13G
|
WKSP / Worksport Ltd.
|
|
|
2,065,892 |
|
|
|
2024-02-14 |
13G
|
VTAK / Catheter Precision, Inc.
|
|
|
752,874 |
|
|
|
2024-02-14 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
3,770,000 |
|
|
|
2024-02-14 |
13G
|
VRAX / Virax Biolabs Group Limited
|
|
|
230,145 |
|
|
|
2024-02-14 |
13G
|
STAF / Staffing 360 Solutions, Inc.
|
|
|
839,217 |
|
|
|
2024-02-14 |
13G
|
SYBX / Synlogic, Inc.
|
|
|
1,285,542 |
|
|
|
2024-02-14 |
13G
|
SLRX / Salarius Pharmaceuticals, Inc.
|
|
|
427,350 |
|
|
|
2024-02-14 |
13G
|
SPRB / Spruce Biosciences, Inc.
|
|
|
2,230,000 |
|
|
|
2024-02-14 |
13G
|
SLGL / Sol-Gel Technologies Ltd.
|
|
|
2,135,000 |
|
|
|
2024-02-14 |
13G
|
SBFM / Sunshine Biopharma, Inc.
|
|
|
2,130,000 |
|
|
|
2024-02-14 |
13G
|
SCNI / Scinai Immunotherapeutics Ltd. - Depositary Receipt (Common Stock)
|
|
|
518,315 |
|
|
|
2024-02-14 |
13G
|
RVPH / Reviva Pharmaceuticals Holdings, Inc.
|
|
|
1,764,000 |
|
|
|
2024-02-14 |
13G
|
RTSL / Rapid Therapeutic Science Laboratories, Inc.
|
|
|
1,491,000 |
|
|
|
2024-02-14 |
13G
|
RELI / Reliance Global Group, Inc.
|
|
|
395,583 |
|
|
|
2024-02-14 |
13G
|
PTCT / PTC Therapeutics, Inc.
|
|
|
6,864,000 |
|
|
|
2024-02-14 |
13G
|
REKR / Rekor Systems, Inc.
|
|
|
7,050,000 |
|
|
|
2024-02-14 |
13G
|
PRFX / PainReform Ltd.
|
|
459,977 |
172,957 |
|
|
|
2024-02-14 |
13G
|
PRTG / Portage Biotech Inc.
|
|
|
1,986,155 |
|
|
|
2024-02-14 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
8,259,048 |
2,499,384 |
|
|
|
2024-02-14 |
13G
|
OFIX / Orthofix Medical Inc.
|
|
|
3,600,000 |
|
|
|
2024-02-14 |
13G
|
OTRK / Ontrak, Inc.
|
|
|
2,886,000 |
|
|
|
2024-02-14 |
13G
|
NVRO / Nevro Corp.
|
|
|
3,176,000 |
|
|
|
2024-02-14 |
13G
|
VSTRD / Netcapital Inc
|
|
|
1,487,138 |
|
|
|
2024-02-14 |
13G
|
NAOV / NanoVibronix, Inc.
|
|
|
227,009 |
|
|
|
2024-02-14 |
13G
|
MURA / Mural Oncology plc
|
|
|
1,658,000 |
|
|
|
2024-02-14 |
13G
|
MYSZ / My Size, Inc.
|
|
|
367,013 |
|
|
|
2024-02-14 |
13G
|
MBRX / Moleculin Biotech, Inc.
|
|
1,000,000 |
3,316,221 |
|
|
|
2024-02-14 |
13G
|
MNTS / Momentus Inc.
|
|
|
492,000 |
|
|
|
2024-02-14 |
13G
|
MOTS / Motus GI Holdings, Inc.
|
|
|
152,450 |
|
|
|
2024-02-14 |
13G
|
MBIO / Mustang Bio, Inc.
|
|
|
974,907 |
|
|
|
2024-02-14 |
13G
|
LGVN / Longeveron Inc.
|
|
|
1,836,000 |
|
|
|
2024-02-14 |
13G
|
LLAP / Terran Orbital Corporation
|
|
|
16,300,000 |
|
|
|
2024-02-14 |
13G
|
KZIA / Kazia Therapeutics Limited - Depositary Receipt (Common Stock)
|
|
|
2,639,218 |
|
|
|
2024-02-14 |
13G
|
IINN / Inspira Technologies Oxy B.H.N. Ltd.
|
|
|
1,528,000 |
|
|
|
2024-02-14 |
13G
|
KANT / Kineta, Inc.
|
|
|
1,054,288 |
|
|
|
2024-02-14 |
13G
|
IDAI / T Stamp Inc.
|
|
|
937,189 |
|
|
|
2024-02-14 |
13G
|
GOVX / GeoVax Labs, Inc.
|
|
188,372 |
3,111,069 |
|
|
|
2024-02-14 |
13G
|
HEPA / Hepion Pharmaceuticals, Inc.
|
|
|
418,000 |
|
|
|
2024-02-14 |
13G
|
GNLN / Greenlane Holdings, Inc.
|
|
|
381,044 |
|
|
|
2024-02-14 |
13G
|
ERAS / Erasca, Inc.
|
|
|
8,096,000 |
|
|
|
2024-02-14 |
13G
|
EYEN / Eyenovia, Inc.
|
|
|
4,378,000 |
|
|
|
2024-02-14 |
13G
|
FGEN / FibroGen, Inc.
|
|
|
9,764,000 |
|
|
|
2024-02-14 |
13G
|
ENVB / Enveric Biosciences, Inc.
|
|
|
273,109 |
|
|
|
2024-02-14 |
13G
|
DRMA / Dermata Therapeutics, Inc.
|
|
|
412,111 |
|
|
|
2024-02-14 |
13G
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
2,442,742 |
|
|
|
2024-02-14 |
13G
|
DPRO / Draganfly Inc.
|
|
|
4,938,978 |
|
|
|
2024-02-14 |
13G
|
COSM / Cosmos Health Inc.
|
|
|
1,504,111 |
|
|
|
2024-02-14 |
13G
|
CVKD / Cadrenal Therapeutics, Inc.
|
|
|
1,399,384 |
|
|
|
2024-02-14 |
13G
|
COEP / Coeptis Therapeutics Holdings, Inc.
|
|
|
3,520,000 |
|
|
|
2024-02-14 |
13G
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
719,980 |
653,946 |
|
|
|
2024-02-14 |
13G
|
BODI / The Beachbody Company, Inc.
|
|
|
401,907 |
|
|
|
2024-02-14 |
13G
|
BSGM / Streamex Corp.
|
|
|
5,600,000 |
|
|
|
2024-02-14 |
13G
|
BKYI / BIO-key International, Inc.
|
|
|
121,494 |
|
|
|
2024-02-14 |
13G
|
BJDX / Bluejay Diagnostics, Inc.
|
|
|
194,525 |
|
|
|
2024-02-14 |
13G
|
BFRI / Biofrontera Inc.
|
|
|
168,105 |
|
|
|
2024-02-14 |
13G
|
ATNF / 180 Life Sciences Corp.
|
|
|
1,112,480 |
|
|
|
2024-02-14 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
9,536,000 |
|
|
|
2024-02-14 |
13G
|
ASNS / Actelis Networks, Inc.
|
|
|
301,490 |
|
|
|
2024-02-14 |
13G
|
AREB / American Rebel Holdings, Inc.
|
|
|
436,000 |
|
|
|
2024-02-14 |
13G
|
APVO / Aptevo Therapeutics Inc.
|
|
0 |
1,731,034 |
|
|
|
2024-02-14 |
13G
|
AQST / Aquestive Therapeutics, Inc.
|
|
|
3,924,000 |
|
|
|
2024-02-14 |
13G
|
ADIL / Adial Pharmaceuticals, Inc.
|
|
|
166,972 |
|
|
|
2024-02-14 |
13G
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
7,214,823 |
|
|
|
2024-02-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
976,000 |
976,000 |
|
|
|
2024-02-14 |
13G
|
SPCB / SuperCom Ltd.
|
|
|
0 |
|
|
|
2024-02-14 |
13G/A
|
XRTX / XORTX Therapeutics Inc.
|
|
|
169,790 |
|
|
|
2024-02-14 |
13G/A
|
VVPR / VivoPower International PLC
|
|
1,916,895 |
153,483 |
|
|
|
2024-02-14 |
13G/A
|
TLPH / Talphera, Inc.
|
|
864,328 |
890,346 |
|
|
|
2024-02-14 |
13G/A
|
TOPS / Top Ships Inc.
|
|
|
242,972 |
|
|
|
2024-02-14 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
4,960,728 |
17,241 |
|
|
|
2024-02-14 |
13G/A
|
SNES / SenesTech, Inc.
|
|
|
117,370 |
|
|
|
2024-02-14 |
13G/A
|
US86882C2044 / Surgalign Holdings, Inc.
|
|
781,837 |
482,321 |
|
|
|
2024-02-14 |
13G/A
|
SCPH / scPharmaceuticals Inc.
|
|
2,148,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
PRSO / Peraso Inc.
|
|
1,438,834 |
234,732 |
|
|
|
2024-02-14 |
13G/A
|
PTNT / Palatin Technologies, Inc.
|
|
1,055,206 |
720,329 |
|
|
|
2024-02-14 |
13G/A
|
RKDA / Arcadia Biosciences, Inc.
|
|
|
58,315 |
|
|
|
2024-02-14 |
13G/A
|
NVIVQ / InVivo Therapeutics Holdings Corp.
|
|
244,999 |
163,100 |
|
|
|
2024-02-14 |
13G/A
|
PALI / Palisade Bio, Inc.
|
|
281,054 |
486,914 |
|
|
|
2024-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,488,000 |
500,000 |
|
|
|
2024-02-14 |
13G/A
|
NBY / NovaBay Pharmaceuticals, Inc.
|
|
191,826 |
380,949 |
|
|
|
2024-02-14 |
13G/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
208,000 |
50,000 |
|
|
|
2024-02-14 |
13G/A
|
MGAM / Mobile Global Esports Inc.
|
|
1,886,793 |
1,072,558 |
|
|
|
2024-02-14 |
13G/A
|
MEDS / TRxADE HEALTH, Inc.
|
|
977,103 |
65,502 |
|
|
|
2024-02-14 |
13G/A
|
IPCIQ / Intellipharmaceutics International Inc.
|
|
3,672,877 |
0 |
|
|
|
2024-02-14 |
13G/A
|
LADX / LadRx Corporation
|
|
|
0 |
|
|
|
2024-02-14 |
13G/A
|
MBOT / Microbot Medical Inc.
|
|
799,180 |
687,654 |
|
|
|
2024-02-14 |
13G/A
|
INPX / Inpixon
|
|
359,117 |
3,846,153 |
|
|
|
2024-02-14 |
13G/A
|
GTEC / Greenland Technologies Holding Corporation
|
|
1,277,307 |
713,995 |
|
|
|
2024-02-14 |
13G/A
|
HOTH / Hoth Therapeutics, Inc.
|
|
144,518 |
228,278 |
|
|
|
2024-02-14 |
13G/A
|
FRPT / Freshpet, Inc.
|
|
2,136,000 |
803,258 |
|
|
|
2024-02-14 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
1,030,000 |
1,501,625 |
|
|
|
2024-02-14 |
13G/A
|
ENTO / Entero Therapeutics, Inc.
|
|
|
78,061 |
|
|
|
2024-02-14 |
13G/A
|
GTBP / GT Biopharma, Inc.
|
|
3,676,186 |
2,175,358 |
|
|
|
2024-02-14 |
13G/A
|
BRSHF / Bruush Oral Care Inc.
|
|
|
821,965 |
|
|
|
2024-02-14 |
13G/A
|
YYAI / Connexa Sports Technologies Inc.
|
|
|
578,088 |
|
|
|
2024-02-14 |
13G/A
|
BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock)
|
|
|
24,951 |
|
|
|
2024-02-14 |
13G/A
|
BIOR / Biora Therapeutics, Inc.
|
|
12,989,648 |
1,074,895 |
|
|
|
2024-02-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
10,224,000 |
3,850,000 |
|
|
|
2024-02-14 |
13G/A
|
AVGR / Avinger, Inc.
|
|
|
67,226 |
|
|
|
2024-02-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
5,333,951 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
1,106,000 |
1,301,114 |
|
|
|
2024-02-14 |
13G/A
|
ACXP / Acurx Pharmaceuticals, Inc.
|
|
880,000 |
723,104 |
|
|
|
2024-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
6,412,000 |
7,384,000 |
|
|
|
2024-02-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
3,396,000 |
4,236,000 |
|
|
|
2024-02-14 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
4,356,000 |
4,650,000 |
|
|
|
2024-02-14 |
13G/A
|
TCBP / TC Biopharm (Holdings) Plc - Depositary Receipt (Common Stock)
|
|
96,253 |
105,938 |
|
|
|
2024-02-14 |
13G/A
|
TRVN / Trevena, Inc.
|
|
784,831 |
1,827,615 |
|
|
|
2024-02-14 |
13G/A
|
US86337R1032 / STRONGHOLD DIGITAL MINING INC A
|
|
2,315,152 |
1,028,642 |
|
|
|
2024-02-14 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
3,201,897 |
4,115,227 |
|
|
|
2024-02-14 |
13G/A
|
SQFT / Presidio Property Trust, Inc.
|
|
1,357,728 |
1,457,261 |
|
|
|
2024-02-14 |
13G/A
|
PTIX / Protagenic Therapeutics, Inc.
|
|
|
240,000 |
|
|
|
2024-02-14 |
13G/A
|
RMTI / Rockwell Medical, Inc.
|
|
1,215,714 |
3,380,534 |
|
|
|
2024-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
16,956,000 |
17,100,000 |
|
|
|
2024-02-14 |
13G/A
|
INM / InMed Pharmaceuticals Inc.
|
|
|
606,214 |
|
|
|
2024-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
6,092,000 |
4,572,000 |
|
|
|
2024-02-14 |
13G/A
|
FREE / Whole Earth Brands, Inc.
|
|
2,475,802 |
2,150,000 |
|
|
|
2024-02-14 |
13G/A
|
GLBS / Globus Maritime Limited
|
|
1,200,000 |
1,200,000 |
|
|
|
2024-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
5,172,000 |
5,200,000 |
|
|
|
2024-02-14 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
2,078,000 |
2,064,000 |
|
|
|
2024-02-14 |
13G/A
|
CFRXQ / ContraFect Corporation
|
|
|
1,395,093 |
|
|
|
2024-02-14 |
13G/A
|
CKPT / Checkpoint Therapeutics, Inc.
|
|
987,211 |
2,715,635 |
|
|
|
2024-02-14 |
13G/A
|
CNSP / CNS Pharmaceuticals, Inc.
|
|
165,456 |
676,203 |
|
|
|
2024-02-14 |
13G/A
|
CDAK / Codiak Biosciences Inc
|
|
2,666,666 |
2,666,666 |
|
|
|
2024-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
0 |
5,800,000 |
|
|
|
2024-02-14 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
955,995 |
1,078,459 |
|
|
|
2024-02-14 |
13G/A
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
2,750,000 |
3,524,000 |
|
|
|
2024-02-14 |
13G/A
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
2,997,111 |
4,626,190 |
|
|
|
2023-06-28 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
4,782,703 |
623,220 |
|
|
|
2023-02-16 |
13G/A
|
ADXN / Addex Therapeutics Ltd
|
|
|
675,295 |
|
|
|
2023-02-14 |
13G
|
MTP / Midatech Pharma Plc - ADR
|
|
|
386,828 |
|
|
|
2023-02-14 |
13G
|
ANU1 / XORTX THERAPEUTICS INC
|
|
|
1,502,516 |
|
|
|
2023-02-14 |
13G/A
|
XCUR / Exicure, Inc.
|
|
|
260,746 |
|
|
|
2023-02-14 |
13G
|
VVPR / VivoPower International PLC
|
|
|
1,916,895 |
|
|
|
2023-02-14 |
13G
|
VYGR / Voyager Therapeutics, Inc.
|
|
0 |
3,396,000 |
|
|
|
2023-02-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
800,000 |
976,000 |
|
|
|
2023-02-14 |
13G
|
TRVN / Trevena, Inc.
|
|
|
784,831 |
|
|
|
2023-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
4,078,000 |
6,412,000 |
|
|
|
2023-02-14 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
2,700,799 |
3,147,200 |
|
|
|
2023-02-14 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,573,462 |
4,960,728 |
|
|
|
2023-02-14 |
13G
|
TOPS / Top Ships Inc.
|
|
|
1,072,725 |
|
|
|
2023-02-14 |
13G
|
TCBP / TC Biopharm (Holdings) Plc - Depositary Receipt (Common Stock)
|
|
|
96,253 |
|
|
|
2023-02-14 |
13G
|
US86882C2044 / Surgalign Holdings, Inc.
|
|
|
781,837 |
|
|
|
2023-02-14 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
4,136,000 |
4,356,000 |
|
|
|
2023-02-14 |
13G/A
|
SQFT / Presidio Property Trust, Inc.
|
|
1,320,552 |
1,357,728 |
|
|
|
2023-02-14 |
13G/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
9,665,756 |
17,000,000 |
|
|
|
2023-02-14 |
13G
|
US81720R4065 / SENESTECH INC
|
|
|
81,855 |
|
|
|
2023-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
6,222,778 |
1,618,411 |
|
|
|
2023-02-14 |
13G
|
US86337R1032 / STRONGHOLD DIGITAL MINING INC A
|
|
|
2,315,152 |
|
|
|
2023-02-14 |
13G
|
SCPH / scPharmaceuticals Inc.
|
|
|
2,148,000 |
|
|
|
2023-02-14 |
13G/A
|
RSLS / ReShape Lifesciences Inc.
|
|
|
25,395 |
|
|
|
2023-02-14 |
13G
|
RKLY / Rockley Photonics Holdings Ltd
|
|
|
14,733,347 |
|
|
|
2023-02-14 |
13G
|
RMTI / Rockwell Medical, Inc.
|
|
|
1,215,714 |
|
|
|
2023-02-14 |
13G
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
16,956,000 |
|
|
|
2023-02-14 |
13G
|
RKDA / Arcadia Biosciences, Inc.
|
|
395,648 |
2,675,409 |
|
|
|
2023-02-14 |
13G
|
PTN / Palatin Technologies, Inc.
|
|
|
1,055,206 |
|
|
|
2023-02-14 |
13G/A
|
RELI / Reliance Global Group, Inc.
|
|
|
948,234 |
|
|
|
2023-02-14 |
13G/A
|
PTIX / Protagenic Therapeutics, Inc.
|
|
960,000 |
960,000 |
|
|
|
2023-02-14 |
13G
|
PRSO / Peraso Inc.
|
|
|
1,438,834 |
|
|
|
2023-02-14 |
13G/A
|
US82452L3024 / SHIFTPIXY INC
|
|
|
488,424 |
|
|
|
2023-02-14 |
13G
|
PALI / Palisade Bio, Inc.
|
|
|
281,054 |
|
|
|
2023-02-14 |
13G
|
NVIVQ / InVivo Therapeutics Holdings Corp.
|
|
|
244,999 |
|
|
|
2023-02-14 |
13G/A
|
OLB / The OLB Group, Inc.
|
|
1,137,610 |
766,096 |
|
|
|
2023-02-14 |
13G
|
NBY / NovaBay Pharmaceuticals, Inc.
|
|
|
191,826 |
|
|
|
2023-02-14 |
13G/A
|
RIME / Algorhythm Holdings, Inc.
|
|
|
163,277 |
|
|
|
2023-02-14 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
3,488,000 |
|
|
|
2023-02-14 |
13G
|
MGNX / MacroGenics, Inc.
|
|
|
6,092,000 |
|
|
|
2023-02-14 |
13G
|
MGAM / Mobile Global Esports Inc.
|
|
|
1,886,793 |
|
|
|
2023-02-14 |
13G
|
MEDS / TRxADE HEALTH, Inc.
|
|
|
977,103 |
|
|
|
2023-02-14 |
13G
|
MBOT / Microbot Medical Inc.
|
|
125,000 |
799,180 |
|
|
|
2023-02-14 |
13G/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,124,000 |
208,000 |
|
|
|
2023-02-14 |
13G/A
|
CYTR / LadRx Corp
|
|
4,304,105 |
4,624,309 |
|
|
|
2023-02-14 |
13G/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
|
89,997 |
|
|
|
2023-02-14 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
3,672,877 |
3,672,877 |
|
|
|
2023-02-14 |
13G/A
|
INPX / Inpixon
|
|
|
359,117 |
|
|
|
2023-02-14 |
13G
|
INM / InMed Pharmaceuticals Inc.
|
|
|
165,685 |
|
|
|
2023-02-14 |
13G
|
IMV / IMV Inc
|
|
|
963,952 |
|
|
|
2023-02-14 |
13G/A
|
HSTO / Histogen Inc.
|
|
|
224,356 |
|
|
|
2023-02-14 |
13G
|
HOTH / Hoth Therapeutics, Inc.
|
|
|
144,518 |
|
|
|
2023-02-14 |
13G
|
GTEC / Greenland Technologies Holding Corporation
|
|
|
1,277,307 |
|
|
|
2023-02-14 |
13G/A
|
SDOT / Sadot Group Inc.
|
|
2,728,553 |
3,201,897 |
|
|
|
2023-02-14 |
13G/A
|
US39878L4077 / GROM SOCIAL ENTE
|
|
|
39,884 |
|
|
|
2023-02-14 |
13G
|
GTBP / GT Biopharma, Inc.
|
|
|
3,676,186 |
|
|
|
2023-02-14 |
13G/A
|
EYRYY / Erytech Pharma
|
|
2,737,252 |
1,629,118 |
|
|
|
2023-02-14 |
13G/A
|
FRPT / Freshpet, Inc.
|
|
2,650,000 |
2,136,000 |
|
|
|
2023-02-14 |
13G
|
US33749P2002 / FIRST WAVE BIOPHARMA
|
|
|
740,405 |
|
|
|
2023-02-14 |
13G/A
|
GLBS / Globus Maritime Limited
|
|
1,200,000 |
1,200,000 |
|
|
|
2023-02-14 |
13G
|
FREE / Whole Earth Brands, Inc.
|
|
|
2,475,802 |
|
|
|
2023-02-14 |
13G
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
1,056,000 |
2,078,000 |
|
|
|
2023-02-14 |
13G/A
|
EFOI / Energy Focus, Inc.
|
|
627,719 |
502,992 |
|
|
|
2023-02-14 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
1,630,000 |
997,004 |
|
|
|
2023-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
3,430,154 |
5,172,000 |
|
|
|
2023-02-14 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
1,030,000 |
1,030,000 |
|
|
|
2023-02-14 |
13G/A
|
CRXT / Clarus Therapeutics Holdings Inc
|
|
2,452,376 |
2,732,169 |
|
|
|
2023-02-14 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
9,572,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
CRTG / The Coretec Group Inc.
|
|
|
13,432,528 |
|
|
|
2023-02-14 |
13G
|
CNSP / CNS Pharmaceuticals, Inc.
|
|
|
165,456 |
|
|
|
2023-02-14 |
13G
|
CNXA / Connexa Sports Technologies Inc.
|
|
|
1,292,418 |
|
|
|
2023-02-14 |
13G
|
CFRX / ContraFect Corp
|
|
|
4,828,644 |
|
|
|
2023-02-14 |
13G
|
CKPT / Checkpoint Therapeutics, Inc.
|
|
|
987,211 |
|
|
|
2023-02-14 |
13G
|
CDAK / Codiak Biosciences Inc
|
|
|
2,666,666 |
|
|
|
2023-02-14 |
13G/A
|
US20717E2000 / CONFORMIS INC
|
|
|
480,000 |
|
|
|
2023-02-14 |
13G/A
|
BXRXQ / Baudax Bio, Inc.
|
|
|
1,165,709 |
|
|
|
2023-02-14 |
13G
|
BRSH / Bruush Oral Care Inc.
|
|
|
1,122,922 |
|
|
|
2023-02-14 |
13G/A
|
BTBT / Bit Digital, Inc.
|
|
4,215,852 |
3,161,889 |
|
|
|
2023-02-14 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
932,052 |
955,995 |
|
|
|
2023-02-14 |
13G
|
BIOR / Biora Therapeutics, Inc.
|
|
|
12,989,648 |
|
|
|
2023-02-14 |
13G
|
US0537348858 / AVINGER INC
|
|
|
789,400 |
|
|
|
2023-02-14 |
13G
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
10,224,000 |
|
|
|
2023-02-14 |
13G
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
|
2,997,111 |
|
|
|
2023-02-14 |
13G
|
APLT / Applied Therapeutics, Inc.
|
|
|
5,333,951 |
|
|
|
2023-02-14 |
13G
|
ARDS / Aridis Pharmaceuticals, Inc.
|
|
|
2,997,111 |
|
|
|
2023-02-14 |
13G
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
2,750,000 |
|
|
|
2023-02-14 |
13G/A
|
ADXN / Addex Therapeutics Ltd
|
|
|
4,038,462 |
|
|
|
2023-02-14 |
13G
|
ACXP / Acurx Pharmaceuticals, Inc.
|
|
|
880,000 |
|
|
|
2023-02-14 |
13G/A
|
TLPH / Talphera, Inc.
|
|
|
864,328 |
|
|
|
2023-02-14 |
13G
|
ABEO / Abeona Therapeutics Inc.
|
|
|
1,106,000 |
|
|
|
2023-02-10 |
13G
|
CYTH / Cyclo Therapeutics, Inc.
|
|
215,326 |
1,030,000 |
|
|
|
2023-02-09 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
4,332,370 |
4,782,703 |
|
|
|
2022-09-23 |
13G
|
FRPT / Freshpet, Inc.
|
|
0 |
2,650,000 |
|
|
|
2022-08-11 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
51,988,442 |
4,332,370 |
|
|
|
2022-06-21 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
2,573,462 |
2,573,462 |
|
|
|
2022-06-17 |
13D/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,572,840 |
2,573,462 |
|
|
|
2022-05-20 |
13D/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,572,840 |
2,572,840 |
|
|
|
2022-03-15 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
50,812,442 |
51,988,442 |
|
|
|
2022-02-15 |
13G
|
SCPS / Scopus BioPharma Inc.
|
|
2,100,000 |
2,100,000 |
|
|
|
2022-02-15 |
13G
|
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
|
|
632,797 |
632,797 |
|
|
|
2022-02-15 |
13G
|
XCUR / Exicure, Inc.
|
|
11,118,800 |
11,118,800 |
|
|
|
2022-02-15 |
13G
|
EFOI / Energy Focus, Inc.
|
|
627,719 |
627,719 |
|
|
|
2022-02-15 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
3,392,000 |
0 |
|
|
|
2022-02-15 |
13G/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
9,592,000 |
9,665,756 |
|
|
|
2022-02-15 |
13G/A
|
CFMS / Conformis Inc.
|
|
9,538,357 |
12,000,000 |
|
|
|
2022-02-15 |
13G
|
INPX / Inpixon
|
|
13,076,541 |
13,076,541 |
|
|
|
2022-02-15 |
13G
|
OLB / The OLB Group, Inc.
|
|
1,137,610 |
1,137,610 |
|
|
|
2022-02-15 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
5,399,277 |
0 |
|
|
|
2022-02-15 |
13G
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
800,000 |
|
|
|
2022-02-15 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
2,624,000 |
2,000,000 |
|
|
|
2022-02-15 |
13G/A
|
RSLS / ReShape Lifesciences Inc.
|
|
869,681 |
1,973,807 |
|
|
|
2022-02-15 |
13G
|
GLBS / Globus Maritime Limited
|
|
1,200,000 |
1,200,000 |
|
|
|
2022-02-15 |
13G/A
|
CTXR / Citius Pharmaceuticals, Inc.
|
|
6,168,361 |
2,425,000 |
|
|
|
2022-02-15 |
13G/A
|
LNTH / Lantheus Holdings, Inc.
|
|
5,200,000 |
0 |
|
|
|
2022-02-15 |
13G/A
|
BIOL / BIOLASE, Inc.
|
|
7,180,000 |
0 |
|
|
|
2022-02-15 |
13G
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
2,916,101 |
723,000 |
|
|
|
2022-02-15 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
10,000,000 |
9,572,000 |
|
|
|
2022-02-15 |
13G
|
PIXY / ShiftPixy, Inc.
|
|
2,870,000 |
2,870,000 |
|
|
|
2022-02-15 |
13G
|
PTIX / Protagenic Therapeutics, Inc.
|
|
960,000 |
960,000 |
|
|
|
2022-02-15 |
13G/A
|
US49721T1016 / KIORA PHARMACEUTICALS INC
|
|
2,131,101 |
2,131,101 |
|
|
|
2022-02-15 |
13G
|
DYNT / Dynatronics Corporation
|
|
1,630,000 |
1,630,000 |
|
|
|
2022-02-15 |
13G
|
CRXT / Clarus Therapeutics Holdings Inc
|
|
2,452,376 |
2,452,376 |
|
|
|
2022-02-15 |
13G
|
EYRYY / Erytech Pharma
|
|
2,737,252 |
2,737,252 |
|
|
|
2022-02-15 |
13G
|
CYTR / LadRx Corp
|
|
4,304,105 |
4,304,105 |
|
|
|
2022-02-15 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
1,056,000 |
1,056,000 |
|
|
|
2022-02-15 |
13G
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,124,000 |
1,124,000 |
|
|
|
2022-02-15 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
440,744 |
932,052 |
|
|
|
2022-02-15 |
13G
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
3,430,154 |
3,430,154 |
|
|
|
2022-02-15 |
13G
|
SQFT / Presidio Property Trust, Inc.
|
|
1,320,552 |
1,320,552 |
|
|
|
2022-02-15 |
13G
|
HSTO / Histogen Inc.
|
|
4,941,178 |
4,941,178 |
|
|
|
2022-02-15 |
13G
|
GRIL / Muscle Maker Inc
|
|
2,728,553 |
2,728,553 |
|
|
|
2022-02-15 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
2,627,978 |
3,672,877 |
|
|
|
2022-02-15 |
13G/A
|
BXRX / Baudax Bio, Inc.
|
|
4,343,469 |
8,869,545 |
|
|
|
2022-02-15 |
13G/A
|
RWLK / ReWalk Robotics Ltd.
|
|
1,394,944 |
2,650,800 |
|
|
|
2022-02-15 |
13G
|
ACRX / Talphera, Inc.
|
|
12,314,479 |
12,314,479 |
|
|
|
2022-02-15 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
3,120,000 |
4,136,000 |
|
|
|
2022-02-15 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
2,742,000 |
0 |
|
|
|
2022-02-14 |
13G
|
SMDM / Singing Machine Co., Inc.
|
|
|
2,469,085 |
|
|
|
2022-02-14 |
13G
|
BTBT / Bit Digital, Inc.
|
|
|
4,215,852 |
|
|
|
2022-02-14 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
4,078,000 |
|
|
|
2022-02-14 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
1,356,000 |
1,056,000 |
|
|
|
2022-02-14 |
13G
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
2,700,799 |
|
|
|
2022-01-20 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
49,412,442 |
50,812,442 |
|
|
|
2021-12-16 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
49,412,442 |
49,412,442 |
|
|
|
2021-11-08 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
49,412,442 |
49,412,442 |
|
|
|
2021-10-15 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
49,000,000 |
49,412,442 |
|
|
|
2021-09-17 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
49,000,000 |
|
|
|
2021-09-01 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
1,342,378 |
1,376,545 |
|
|
|
2021-08-31 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
1,333,334 |
1,342,378 |
|
|
|
2021-08-13 |
13G
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
2,916,101 |
2,916,101 |
|
|
|
2021-08-03 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
4,799,101 |
2,916,101 |
|
|
|
2021-07-09 |
13D/A
|
TENX / Tenax Therapeutics, Inc.
|
|
2,773,455 |
2,572,840 |
|
|
|
2021-06-30 |
13G/A
|
RSLS / ReShape Lifesciences Inc.
|
|
|
869,681 |
|
|
|
2021-06-30 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
|
869,681 |
|
|
|
2021-06-25 |
13D
|
RSLS / ReShape Lifesciences Inc.
|
|
|
7,223,346 |
|
|
|
2021-06-22 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
12,962,100 |
0 |
|
|
|
2021-02-16 |
13G/A
|
PRFX / PainReform Ltd.
|
|
|
459,977 |
|
|
|
2021-02-16 |
13G/A
|
CFMS / Conformis Inc.
|
|
8,746,502 |
9,538,357 |
|
|
|
2021-02-16 |
13G/A
|
ADIL / Adial Pharmaceuticals, Inc.
|
|
712,500 |
712,500 |
|
|
|
2021-02-16 |
13G/A
|
LNTH / Lantheus Holdings, Inc.
|
|
2,000,000 |
5,200,000 |
|
|
|
2021-02-16 |
13G/A
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
2,888,000 |
3,120,000 |
|
|
|
2021-02-16 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
1,576,471 |
1,280,930 |
|
|
|
2021-02-16 |
13G/A
|
67424L100 / Obalon Therapeutics Inc
|
|
1,100,000 |
1,100,000 |
|
|
|
2021-02-16 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,976,000 |
5,399,277 |
|
|
|
2021-02-16 |
13G/A
|
SKYE / Skye Bioscience, Inc.
|
|
15,187,057 |
12,603,182 |
|
|
|
2021-02-16 |
13G
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
1,356,000 |
|
|
|
2021-02-16 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
1,230,000 |
2,624,000 |
|
|
|
2021-02-16 |
13G/A
|
BIOL / BIOLASE, Inc.
|
|
6,057,388 |
7,180,000 |
|
|
|
2021-02-16 |
13G/A
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
756,000 |
364,000 |
|
|
|
2021-02-16 |
13G
|
IPCI / Intellipharmaceutics International Inc.
|
|
575,099 |
2,627,978 |
|
|
|
2021-02-16 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
598,399 |
0 |
|
|
|
2021-02-16 |
13G/A
|
MNKKQ / Mallinckrodt Plc
|
|
5,680,000 |
0 |
|
|
|
2021-02-16 |
13G/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
7,858,000 |
9,592,000 |
|
|
|
2021-02-16 |
13G
|
PTE / PolarityTE Inc
|
|
|
2,789,664 |
|
|
|
2021-02-16 |
13G
|
RWLK / ReWalk Robotics Ltd.
|
|
938,463 |
1,394,944 |
|
|
|
2021-02-16 |
13G
|
BXRX / Baudax Bio, Inc.
|
|
899,576 |
4,343,469 |
|
|
|
2021-02-16 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
2,000,000 |
3,392,000 |
|
|
|
2021-02-16 |
13G
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
1,750,000 |
440,744 |
|
|
|
2021-02-16 |
13G/A
|
OBSV / ObsEva SA.
|
|
5,053,322 |
2,889,432 |
|
|
|
2021-02-16 |
13G/A
|
HSDT / Helius Medical Technologies, Inc.
|
|
1,910,062 |
77,888 |
|
|
|
2021-02-16 |
13G/A
|
MOTS / Motus GI Holdings, Inc.
|
|
3,090,470 |
1,675,086 |
|
|
|
2021-02-16 |
13G/A
|
ETTX / Entasis Therapeutics Holdings Inc
|
|
3,510,981 |
1,863,198 |
|
|
|
2021-02-16 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
982,232 |
1,630,000 |
|
|
|
2021-02-16 |
13G/A
|
CTXR / Citius Pharmaceuticals, Inc.
|
|
3,210,927 |
6,168,361 |
|
|
|
2021-02-16 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
5,378,000 |
10,000,000 |
|
|
|
2021-02-16 |
13G/A
|
CLBS / Caladrius Biosciences Inc
|
|
763,535 |
801,148 |
|
|
|
2021-02-16 |
13G/A
|
BCOR / Grayscale Funds Trust - Grayscale Bitcoin Adopters ETF
|
|
2,548,000 |
1,328,000 |
|
|
|
2021-02-16 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
5,025,437 |
0 |
|
|
|
2021-02-16 |
13G/A
|
AEZS / COSCIENS Biopharma Inc.
|
|
1,213,738 |
2,808,930 |
|
|
|
2021-02-16 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
2,196,000 |
2,742,000 |
|
|
|
2021-01-12 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
40,612,442 |
43,332,442 |
|
|
|
2021-01-12 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
3,245,000 |
4,799,101 |
|
|
|
2020-12-21 |
13D
|
AYTU / Aytu BioPharma, Inc.
|
|
407,373 |
1,333,334 |
|
|
|
2020-12-11 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
28,861,787 |
215,326 |
|
|
|
2020-11-10 |
13G/A
|
67424L100 / Obalon Therapeutics Inc
|
|
699,685 |
1,100,000 |
|
|
|
2020-10-07 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
4,300,000 |
0 |
|
|
|
2020-10-05 |
13G
|
GOVX / GeoVax Labs, Inc.
|
|
|
188,372 |
|
|
|
2020-10-05 |
13G
|
CFMS / Conformis Inc.
|
|
|
8,746,502 |
|
|
|
2020-10-02 |
13G
|
RMTI / Rockwell Medical, Inc.
|
|
|
4,843,093 |
|
|
|
2020-09-25 |
13G
|
67424L100 / Obalon Therapeutics Inc
|
|
|
699,685 |
|
|
|
2020-09-24 |
13G
|
CLRO / ClearOne, Inc.
|
|
|
965,624 |
|
|
|
2020-09-16 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
11,762,000 |
12,962,100 |
|
|
|
2020-09-14 |
13G
|
OBSV / ObsEva SA.
|
|
|
5,053,322 |
|
|
|
2020-09-10 |
13G
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
756,000 |
|
|
|
2020-09-08 |
13G
|
PBLA / Panbela Therapeutics, Inc.
|
|
|
497,029 |
|
|
|
2020-09-08 |
13G
|
MOTS / Motus GI Holdings, Inc.
|
|
|
3,090,470 |
|
|
|
2020-09-08 |
13G
|
CWBR / CohBar, Inc.
|
|
|
2,456,250 |
|
|
|
2020-09-08 |
13G
|
ETTX / Entasis Therapeutics Holdings Inc
|
|
|
3,510,981 |
|
|
|
2020-09-04 |
13G
|
NAOV / NanoVibronix, Inc.
|
|
|
0 |
|
|
|
2020-08-31 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
12,050,000 |
28,861,787 |
|
|
|
2020-08-20 |
13G
|
NVCN / Neovasc Inc
|
|
838,333 |
1,163,131 |
|
|
|
2020-08-20 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
11,747,502 |
11,762,000 |
|
|
|
2020-08-10 |
13G
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
991,010 |
7,858,000 |
|
|
|
2020-08-10 |
13G
|
OCUP / Opus Genetics, Inc.
|
|
2,535,567 |
44,145 |
|
|
|
2020-08-10 |
13G
|
SKYE / Skye Bioscience, Inc.
|
|
|
15,187,057 |
|
|
|
2020-08-10 |
13G
|
RMED / Catheter Precision Inc.
|
|
1,870,662 |
3,806,094 |
|
|
|
2020-07-31 |
13G
|
BCOR / Grayscale Funds Trust - Grayscale Bitcoin Adopters ETF
|
|
|
2,548,000 |
|
|
|
2020-07-31 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
41,740,442 |
40,612,442 |
|
|
|
2020-07-31 |
13G
|
BIOL / BIOLASE, Inc.
|
|
2,500,000 |
6,057,388 |
|
|
|
2020-07-31 |
13D/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,460,019 |
0 |
|
|
|
2020-07-16 |
13D
|
TENX / Tenax Therapeutics, Inc.
|
|
421,140 |
2,773,455 |
|
|
|
2020-07-10 |
13G
|
GEVO / Gevo, Inc.
|
|
|
2,034,870 |
|
|
|
2020-07-10 |
13G
|
ITRM / Iterum Therapeutics plc
|
|
891,145 |
1,114,145 |
|
|
|
2020-07-10 |
13G
|
RWLK / ReWalk Robotics Ltd.
|
|
648,166 |
938,463 |
|
|
|
2020-07-06 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
5,018,443 |
8,259,048 |
|
|
|
2020-06-30 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
16,785,583 |
145,523 |
|
|
|
2020-06-30 |
13D/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,460,019 |
1,460,019 |
|
|
|
2020-06-26 |
13G
|
BBI / Brickell Biotech Inc
|
|
0 |
1,331,248 |
|
|
|
2020-06-22 |
13G
|
NVCN / Neovasc Inc
|
|
|
838,333 |
|
|
|
2020-06-19 |
13G
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
390,720 |
719,980 |
|
|
|
2020-06-19 |
13G
|
ADIL / Adial Pharmaceuticals, Inc.
|
|
|
712,500 |
|
|
|
2020-06-18 |
13G
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
|
398,692 |
|
|
|
2020-06-18 |
13G
|
BIOL / BIOLASE, Inc.
|
|
|
2,500,000 |
|
|
|
2020-06-18 |
13G
|
TMDI / Titan Medical Inc
|
|
2,067,939 |
3,727,449 |
|
|
|
2020-06-12 |
13G
|
ITRM / Iterum Therapeutics plc
|
|
|
891,145 |
|
|
|
2020-06-12 |
13G
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
1,319,617 |
|
|
|
2020-06-11 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
39,690,956 |
41,740,442 |
|
|
|
2020-06-11 |
13G
|
CBLI / Cytocom Inc
|
|
|
519,217 |
|
|
|
2020-06-11 |
13D/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,419,507 |
1,460,019 |
|
|
|
2020-06-09 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
8,400,000 |
16,785,583 |
|
|
|
2020-06-05 |
13G
|
ZOM / Zomedica Corp.
|
|
6,768,444 |
15,315,997 |
|
|
|
2020-06-05 |
13G
|
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
1,038,084 |
|
|
|
2020-05-29 |
13G
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
1,576,471 |
|
|
|
2020-05-29 |
13G
|
RMED / Catheter Precision Inc.
|
|
|
1,870,662 |
|
|
|
2020-05-29 |
13G
|
PALI / Palisade Bio, Inc.
|
|
|
908,572 |
|
|
|
2020-05-27 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
10,350,000 |
8,400,000 |
|
|
|
2020-05-26 |
13G
|
LNTH / Lantheus Holdings, Inc.
|
|
|
2,000,000 |
|
|
|
2020-05-21 |
13G
|
CHEKW / Check-Cap Ltd. Warrants
|
|
1,321,757 |
1,584,604 |
|
|
|
2020-05-18 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
15,950,000 |
10,350,000 |
|
|
|
2020-05-18 |
13G
|
VBLT / Vascular Biogenics Ltd
|
|
|
2,198,560 |
|
|
|
2020-05-15 |
13G
|
MYSZ / My Size, Inc.
|
|
136,589 |
375,321 |
|
|
|
2020-05-15 |
13G
|
POAI / Predictive Oncology Inc.
|
|
|
552,686 |
|
|
|
2020-05-15 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
2,104,107 |
5,018,443 |
|
|
|
2020-05-14 |
13G
|
IL0011177958 / Intec Pharma Ltd
|
|
2,731,268 |
3,637,880 |
|
|
|
2020-05-14 |
13G
|
TMDI / Titan Medical Inc
|
|
|
2,067,939 |
|
|
|
2020-05-07 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
39,563,762 |
39,690,956 |
|
|
|
2020-05-05 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
25,200,000 |
15,950,000 |
|
|
|
2020-05-04 |
13G
|
CLBS / Caladrius Biosciences Inc
|
|
|
763,535 |
|
|
|
2020-04-30 |
13G
|
CHEKW / Check-Cap Ltd. Warrants
|
|
972,215 |
1,321,757 |
|
|
|
2020-04-29 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
5,108,921 |
407,373 |
|
|
|
2020-04-24 |
13G
|
PULM / Pulmatrix, Inc.
|
|
|
1,320,180 |
|
|
|
2020-04-24 |
13G
|
NVIV / InVivo Therapeutics Holdings Corp.
|
|
|
254,597 |
|
|
|
2020-04-13 |
13G
|
/ VIVUS, Inc.
|
|
|
0 |
|
|
|
2020-04-08 |
13G
|
PHIO / Phio Pharmaceuticals Corp.
|
|
120,742 |
240,592 |
|
|
|
2020-04-08 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
5,000,001 |
5,108,921 |
|
|
|
2020-04-06 |
13G
|
THMO / ThermoGenesis Holdings, Inc.
|
|
|
0 |
|
|
|
2020-04-03 |
13G
|
BXRX / Baudax Bio, Inc.
|
|
|
899,576 |
|
|
|
2020-04-01 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
|
11,747,502 |
|
|
|
2020-03-30 |
13G
|
HSDT / Helius Medical Technologies, Inc.
|
|
|
1,910,062 |
|
|
|
2020-03-26 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
5,378,000 |
|
|
|
2020-03-23 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
760,000 |
2,104,107 |
|
|
|
2020-03-23 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
421,140 |
|
|
|
2020-03-20 |
13D/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,419,507 |
1,419,507 |
|
|
|
2020-03-19 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
37,582,543 |
39,563,762 |
|
|
|
2020-03-16 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
40,625,230 |
37,582,543 |
|
|
|
2020-03-16 |
13G
|
SNES / SenesTech, Inc.
|
|
|
92,884 |
|
|
|
2020-03-16 |
13G
|
NVIV / InVivo Therapeutics Holdings Corp.
|
|
|
111,376 |
|
|
|
2020-03-16 |
13G
|
ZSAN / Zosano Pharma Corp
|
|
1,905,665 |
2,853,921 |
|
|
|
2020-03-13 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
12,362,140 |
5,000,001 |
|
|
|
2020-03-13 |
13G
|
AIKI / AIkido Pharma Inc
|
|
|
0 |
|
|
|
2020-03-12 |
13G
|
SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
2,888,000 |
|
|
|
2020-03-06 |
13G
|
NOVN / Novan Inc
|
|
|
2,548,209 |
|
|
|
2020-03-06 |
13G
|
MNKKQ / Mallinckrodt Plc
|
|
4,180,000 |
5,680,000 |
|
|
|
2020-03-05 |
13G
|
VYGR / Voyager Therapeutics, Inc.
|
|
1,624,000 |
2,000,000 |
|
|
|
2020-03-05 |
13G
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
2,685,273 |
|
|
|
2020-02-28 |
13G
|
AEZS / COSCIENS Biopharma Inc.
|
|
1,022,247 |
1,213,738 |
|
|
|
2020-02-21 |
13G
|
ZOM / Zomedica Corp.
|
|
|
6,768,444 |
|
|
|
2020-02-21 |
13G
|
ZSAN / Zosano Pharma Corp
|
|
0 |
1,905,665 |
|
|
|
2020-02-20 |
13G
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
174,581 |
390,720 |
|
|
|
2020-02-20 |
13D/A
|
INNV / InnovAge Holding Corp.
|
|
300,000 |
0 |
|
|
|
2020-02-20 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
8,378,692 |
12,362,140 |
|
|
|
2020-02-14 |
13G/A
|
SEEL / Seelos Therapeutics, Inc.
|
|
318,730 |
0 |
|
|
|
2020-02-14 |
13G/A
|
MNKKQ / Mallinckrodt Plc
|
|
7,160,000 |
4,180,000 |
|
|
|
2020-02-14 |
13G/A
|
TROV / TrovaGene, Inc.
|
|
776,064 |
0 |
|
|
|
2020-02-14 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
364,476 |
598,399 |
|
|
|
2020-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
0 |
|
|
|
2020-02-14 |
13G/A
|
CTXR / Citius Pharmaceuticals, Inc.
|
|
1,893,490 |
3,210,927 |
|
|
|
2020-02-14 |
13G/A
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
1,968,000 |
1,258,000 |
|
|
|
2020-02-14 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
3,232,419 |
1,750,000 |
|
|
|
2020-02-14 |
13G
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
120,742 |
|
|
|
2020-02-14 |
13G
|
RWLK / ReWalk Robotics Ltd.
|
|
313,246 |
648,166 |
|
|
|
2020-02-14 |
13G
|
SLRX / Salarius Pharmaceuticals, Inc.
|
|
|
634,763 |
|
|
|
2020-02-14 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
4,765,835 |
5,025,437 |
|
|
|
2020-02-14 |
13G/A
|
CYTH / Cyclo Therapeutics, Inc.
|
|
12,000,000 |
12,050,000 |
|
|
|
2020-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
640,000 |
1,086,143 |
|
|
|
2020-02-14 |
13G/A
|
MTP / Midatech Pharma Plc - ADR
|
|
45,935,560 |
1,233,974 |
|
|
|
2020-02-14 |
13G/A
|
DPLO / Diplomat Pharmacy, Inc.
|
|
4,310,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
3,500,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
NBY / NovaBay Pharmaceuticals, Inc.
|
|
1,747,944 |
1,465,426 |
|
|
|
2020-02-14 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
6,936,000 |
228,000 |
|
|
|
2020-02-14 |
13G/A
|
SPHS / Sophiris Bio Inc
|
|
2,538,463 |
1,867,138 |
|
|
|
2020-02-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
1,600,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
10,300,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
4,000,000 |
4,300,000 |
|
|
|
2020-02-14 |
13G/A
|
CENN / Cenntro Inc.
|
|
6,752,000 |
221,471 |
|
|
|
2020-02-14 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,625,000 |
2,196,000 |
|
|
|
2020-02-14 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
846,593 |
982,232 |
|
|
|
2020-02-14 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,878,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ATEC / Alphatec Holdings, Inc.
|
|
3,338,414 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
3,268,000 |
2,976,000 |
|
|
|
2020-02-14 |
13G/A
|
ALRN / Rein Therapeutics Inc.
|
|
2,137,089 |
1,460,620 |
|
|
|
2020-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
3,278,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
1,590,000 |
1,230,000 |
|
|
|
2020-02-14 |
13G/A
|
DFFN / Diffusion Pharmaceuticals Inc
|
|
256,516 |
1,755,156 |
|
|
|
2020-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
5,700,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
2,836,000 |
1,624,000 |
|
|
|
2020-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
2,100,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
0 |
|
|
|
2020-02-07 |
13G
|
IL0011177958 / Intec Pharma Ltd
|
|
|
2,731,268 |
|
|
|
2020-02-06 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
39,368,948 |
40,625,230 |
|
|
|
2020-01-27 |
13G
|
NHWK / NightHawk Biosciences, Inc.
|
|
|
2,901,635 |
|
|
|
2020-01-24 |
13G
|
AEMD / Aethlon Medical, Inc.
|
|
221,609 |
315,648 |
|
|
|
2020-01-24 |
13G
|
MYSZ / My Size, Inc.
|
|
|
136,589 |
|
|
|
2020-01-23 |
13D
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
327,447 |
1,419,507 |
|
|
|
2020-01-15 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
3,245,000 |
3,245,000 |
|
|
|
2020-01-10 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
3,245,000 |
3,245,000 |
|
|
|
2020-01-10 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
5,292,308 |
7,286,201 |
|
|
|
2019-12-27 |
13G
|
CAPR / Capricor Therapeutics, Inc.
|
|
|
243,184 |
|
|
|
2019-12-27 |
13G
|
EKSO / Ekso Bionics Holdings, Inc.
|
|
|
4,356,559 |
|
|
|
2019-12-23 |
13G/A
|
VLRX / Valeritas, Inc.
|
|
|
924,693 |
|
|
|
2019-12-20 |
13G
|
AEMD / Aethlon Medical, Inc.
|
|
|
221,609 |
|
|
|
2019-12-20 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
6,222,778 |
|
|
|
2019-12-19 |
13G
|
ACET / Adicet Bio, Inc.
|
|
|
3,500,000 |
|
|
|
2019-12-19 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
430,536 |
5,292,308 |
|
|
|
2019-12-13 |
13G
|
MYMD / MyMD Pharmaceuticals, Inc.
|
|
|
190,714 |
|
|
|
2019-12-06 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
39,368,948 |
39,368,948 |
|
|
|
2019-11-27 |
13G
|
BPTH / Bio-Path Holdings, Inc.
|
|
92,329 |
151,515 |
|
|
|
2019-11-25 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
364,476 |
364,476 |
|
|
|
2019-11-22 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
364,476 |
|
|
|
2019-11-22 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
25,000,000 |
25,200,000 |
|
|
|
2019-11-18 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
252,630,682 |
10,520,207 |
|
|
|
2019-11-08 |
13G
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
327,447 |
|
|
|
2019-11-07 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
39,368,948 |
39,368,948 |
|
|
|
2019-11-07 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
8,380,064 |
8,378,692 |
|
|
|
2019-11-04 |
13G
|
MTP / Midatech Pharma Plc - ADR
|
|
45,935,560 |
45,935,560 |
|
|
|
2019-11-01 |
13G
|
MTP / Midatech Pharma Plc - ADR
|
|
|
45,935,560 |
|
|
|
2019-11-01 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
25,000,000 |
25,000,000 |
|
|
|
2019-11-01 |
13G
|
OPGN / OpGen, Inc.
|
|
454,067 |
172,631 |
|
|
|
2019-11-01 |
13G
|
TROV / TrovaGene, Inc.
|
|
|
776,064 |
|
|
|
2019-10-18 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
2,392,500 |
3,245,000 |
|
|
|
2019-10-16 |
13G
|
MNKKQ / Mallinckrodt Plc
|
|
7,160,000 |
7,160,000 |
|
|
|
2019-10-16 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
7,695,064 |
8,380,064 |
|
|
|
2019-10-15 |
13G
|
MNKKQ / Mallinckrodt Plc
|
|
3,600,000 |
7,160,000 |
|
|
|
2019-10-08 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
25,000,000 |
25,000,000 |
|
|
|
2019-10-07 |
13D/A
|
VXRT / Vaxart, Inc.
|
|
24,000,000 |
25,000,000 |
|
|
|
2019-10-03 |
13G
|
PSTV / Plus Therapeutics, Inc.
|
|
|
61,427 |
|
|
|
2019-10-02 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
2,392,500 |
2,392,500 |
|
|
|
2019-10-02 |
13G/A
|
DFRG / Del Frisco's Restaurant Group, Inc.
|
|
6,435,000 |
0 |
|
|
|
2019-10-01 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
17,812,500 |
2,392,500 |
|
|
|
2019-10-01 |
13D
|
VXRT / Vaxart, Inc.
|
|
24,000,000 |
24,000,000 |
|
|
|
2019-09-30 |
13D
|
VXRT / Vaxart, Inc.
|
|
|
24,000,000 |
|
|
|
2019-09-30 |
13D/A
|
RSLS / ReShape Lifesciences Inc.
|
|
244,561,824 |
252,630,682 |
|
|
|
2019-09-27 |
13G
|
AEZS / COSCIENS Biopharma Inc.
|
|
|
1,022,247 |
|
|
|
2019-09-27 |
13G
|
NSPR / InspireMD, Inc.
|
|
908,864 |
101,746 |
|
|
|
2019-09-26 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
430,536 |
430,536 |
|
|
|
2019-09-25 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
296,480 |
430,536 |
|
|
|
2019-09-19 |
13D/A
|
INNV / InnovAge Holding Corp.
|
|
300,000 |
300,000 |
|
|
|
2019-09-18 |
13D/A
|
INNV / InnovAge Holding Corp.
|
|
24,239,503 |
300,000 |
|
|
|
2019-09-18 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
5,120,064 |
7,695,064 |
|
|
|
2019-09-16 |
13G
|
RKDA / Arcadia Biosciences, Inc.
|
|
|
395,648 |
|
|
|
2019-09-11 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
36,830,000 |
39,368,948 |
|
|
|
2019-09-06 |
13G
|
SPHS / Sophiris Bio Inc
|
|
|
2,538,463 |
|
|
|
2019-08-26 |
13G
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
3,232,419 |
|
|
|
2019-08-26 |
13G
|
DPLO / Diplomat Pharmacy, Inc.
|
|
|
4,310,000 |
|
|
|
2019-08-19 |
13G
|
NBY / NovaBay Pharmaceuticals, Inc.
|
|
|
1,747,944 |
|
|
|
2019-07-29 |
13G/A
|
CENN / Cenntro Inc.
|
|
|
6,752,000 |
|
|
|
2019-07-03 |
13G
|
MNKKQ / Mallinckrodt Plc
|
|
|
3,600,000 |
|
|
|
2019-06-28 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
4,000,000 |
4,000,000 |
|
|
|
2019-06-27 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
3,345,000 |
4,000,000 |
|
|
|
2019-06-24 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
0 |
3,268,000 |
|
|
|
2019-06-24 |
13G
|
NAVB / Navidea Biopharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2019-06-24 |
13D
|
RSLS / ReShape Lifesciences Inc.
|
|
|
244,561,824 |
|
|
|
2019-06-17 |
13G
|
RWLK / ReWalk Robotics Ltd.
|
|
|
313,246 |
|
|
|
2019-06-13 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
1,095,926 |
640,000 |
|
|
|
2019-06-10 |
13G
|
CYTH / Cyclo Therapeutics, Inc.
|
|
|
12,000,000 |
|
|
|
2019-06-07 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
1,095,926 |
|
|
|
2019-06-05 |
13G
|
88907J107 / Novus Therapeutics, Inc.
|
|
|
657,647 |
|
|
|
2019-06-03 |
13G
|
ONCS / OncoSec Medical Inc
|
|
|
550,158 |
|
|
|
2019-06-03 |
13G
|
DFFN / Diffusion Pharmaceuticals Inc
|
|
|
256,516 |
|
|
|
2019-05-30 |
13G
|
CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock)
|
|
|
174,581 |
|
|
|
2019-05-20 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
1,878,000 |
3,345,000 |
|
|
|
2019-05-15 |
13G/A
|
DFRG / Del Frisco's Restaurant Group, Inc.
|
|
4,528,000 |
6,435,000 |
|
|
|
2019-04-25 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,590,000 |
|
|
|
2019-04-23 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
5,120,064 |
5,120,064 |
|
|
|
2019-04-22 |
13D/A
|
AYTU / Aytu BioPharma, Inc.
|
|
2,000,000 |
5,120,064 |
|
|
|
2019-04-08 |
13G
|
ALRN / Rein Therapeutics Inc.
|
|
|
2,137,089 |
|
|
|
2019-04-08 |
13G
|
MBRX / Moleculin Biotech, Inc.
|
|
|
1,000,000 |
|
|
|
2019-04-04 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
16,802,500 |
17,812,500 |
|
|
|
2019-03-25 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
2,100,000 |
|
|
|
2019-03-20 |
13G
|
APVO / Aptevo Therapeutics Inc.
|
|
|
4,765,835 |
|
|
|
2019-03-11 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
36,830,000 |
36,830,000 |
|
|
|
2019-03-08 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
36,414,514 |
36,830,000 |
|
|
|
2019-03-08 |
13D/A
|
CLVS / Clovis Oncology Inc
|
|
5,150,000 |
2,025,000 |
|
|
|
2019-02-25 |
13G
|
/ Achaogen Inc
|
|
|
3,178,884 |
|
|
|
2019-02-19 |
13G/A
|
CENN / Cenntro Inc.
|
|
|
2,625,110 |
|
|
|
2019-02-19 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
3,634,316 |
585,185 |
|
|
|
2019-02-15 |
13D
|
AYTU / Aytu BioPharma, Inc.
|
|
448,217 |
2,000,000 |
|
|
|
2019-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
3,658,000 |
3,278,000 |
|
|
|
2019-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
448,000 |
|
|
|
2019-02-14 |
13G/A
|
APRN / Blue Apron Holdings Inc - Class A
|
|
2,650,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
FRPT / Freshpet, Inc.
|
|
2,236,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
2,870,000 |
2,878,000 |
|
|
|
2019-02-14 |
13G/A
|
CTXR / Citius Pharmaceuticals, Inc.
|
|
1,703,912 |
1,893,490 |
|
|
|
2019-02-14 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
565,800 |
575,099 |
|
|
|
2019-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
3,450,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
OCGN / Ocugen, Inc.
|
|
1,333,333 |
1,333,333 |
|
|
|
2019-02-14 |
13G/A
|
ATEC / Alphatec Holdings, Inc.
|
|
2,550,361 |
3,338,414 |
|
|
|
2019-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,678,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
ATNM / Actinium Pharmaceuticals, Inc.
|
|
4,464,000 |
6,076,815 |
|
|
|
2019-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
2,164,000 |
1,911,130 |
|
|
|
2019-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
10,000,000 |
10,300,000 |
|
|
|
2019-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
|
3,278,000 |
|
|
|
2019-02-14 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
814,670 |
846,593 |
|
|
|
2019-02-14 |
13D/A
|
SEEL / Seelos Therapeutics, Inc.
|
|
|
318,730 |
|
|
|
2019-02-14 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,856,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,692,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
DFRG / Del Frisco's Restaurant Group, Inc.
|
|
3,724,000 |
4,528,000 |
|
|
|
2019-02-14 |
13G/A
|
VLRX / Valeritas, Inc.
|
|
19,000,000 |
19,850,000 |
|
|
|
2019-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
6,050,000 |
5,700,000 |
|
|
|
2019-02-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
1,724,000 |
2,836,000 |
|
|
|
2019-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
500,000 |
448,000 |
|
|
|
2019-02-14 |
13G/A
|
OPGN / OpGen, Inc.
|
|
358,505 |
454,067 |
|
|
|
2019-02-14 |
13G/A
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
1,672,000 |
1,968,000 |
|
|
|
2019-02-14 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
6,936,000 |
6,936,000 |
|
|
|
2019-02-14 |
13G/A
|
PALI / Palisade Bio, Inc.
|
|
1,030,023 |
925,157 |
|
|
|
2019-02-14 |
13G/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
1,607,500 |
296,480 |
|
|
|
2019-02-14 |
13G/A
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
1,832,000 |
1,878,000 |
|
|
|
2019-02-05 |
13G
|
RNN / Rexahn Pharmaceuticals, Inc,
|
|
2,535,567 |
2,535,567 |
|
|
|
2019-02-04 |
13G
|
RNN / Rexahn Pharmaceuticals, Inc,
|
|
|
2,535,567 |
|
|
|
2019-01-28 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
0 |
1,625,000 |
|
|
|
2019-01-28 |
13G
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2019-01-28 |
13G
|
BPTH / Bio-Path Holdings, Inc.
|
|
|
92,329 |
|
|
|
2019-01-25 |
13G
|
HMNY / Helios and Matheson Analytics Inc.
|
|
|
105,122,522 |
|
|
|
2019-01-25 |
13G/A
|
MBOT / Microbot Medical Inc.
|
|
|
125,000 |
|
|
|
2019-01-17 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
4,360,500 |
1,815,795 |
|
|
|
2019-01-09 |
13D
|
INNV / InnovAge Holding Corp.
|
|
|
24,239,503 |
|
|
|
2019-01-08 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
502,881 |
448,217 |
|
|
|
2019-01-02 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
36,414,514 |
36,414,514 |
|
|
|
2018-12-31 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
31,786,114 |
36,414,514 |
|
|
|
2018-12-10 |
13G
|
OVID / Ovid Therapeutics Inc.
|
|
|
1,600,000 |
|
|
|
2018-11-21 |
13G
|
VLRX / Valeritas, Inc.
|
|
|
19,000,000 |
|
|
|
2018-11-13 |
13G
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
1,672,000 |
|
|
|
2018-11-05 |
13D
|
CLVS / Clovis Oncology Inc
|
|
|
5,150,000 |
|
|
|
2018-11-05 |
13G
|
PALI / Palisade Bio, Inc.
|
|
|
1,030,023 |
|
|
|
2018-10-31 |
13G/A
|
CENN / Cenntro Inc.
|
|
|
3,892,000 |
|
|
|
2018-10-18 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
8,227,500 |
565,800 |
|
|
|
2018-10-11 |
13G
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
500,000 |
|
|
|
2018-10-11 |
13G
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
500,000 |
|
|
|
2018-09-27 |
13D
|
SEEL / Seelos Therapeutics, Inc.
|
|
850,000 |
4,600,000 |
|
|
|
2018-09-27 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
31,765,714 |
31,786,114 |
|
|
|
2018-09-24 |
13G
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
6,050,000 |
|
|
|
2018-09-21 |
13G
|
VYGR / Voyager Therapeutics, Inc.
|
|
|
1,724,000 |
|
|
|
2018-08-31 |
13G
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
176,869 |
176,869 |
|
|
|
2018-08-30 |
13G
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
0 |
176,869 |
|
|
|
2018-08-21 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
31,765,714 |
31,765,714 |
|
|
|
2018-08-21 |
13G
|
SAVA / Cassava Sciences, Inc.
|
|
2,164,000 |
2,164,000 |
|
|
|
2018-08-20 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
30,335,714 |
31,765,714 |
|
|
|
2018-08-20 |
13G
|
SAVA / Cassava Sciences, Inc.
|
|
|
2,164,000 |
|
|
|
2018-08-20 |
13G
|
CTXR / Citius Pharmaceuticals, Inc.
|
|
|
1,703,912 |
|
|
|
2018-08-16 |
13G
|
BDSI / Biodelivery Sciences International
|
|
0 |
3,692,000 |
|
|
|
2018-08-10 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
16,742,500 |
16,802,500 |
|
|
|
2018-08-09 |
13G/A
|
DFRG / Del Frisco's Restaurant Group, Inc.
|
|
1,212,000 |
3,724,000 |
|
|
|
2018-08-06 |
13G
|
ZOES / Zoe's Kitchen, Inc.
|
|
|
1,000,000 |
|
|
|
2018-07-30 |
13G
|
STDY / SteadyMed Ltd.
|
|
|
1,451,387 |
|
|
|
2018-07-26 |
13G
|
DFRG / Del Frisco's Restaurant Group, Inc.
|
|
|
1,212,000 |
|
|
|
2018-07-23 |
13G
|
AVGR / Avinger, Inc.
|
|
|
602,521 |
|
|
|
2018-07-12 |
13G
|
ORMP / Oramed Pharmaceuticals Inc.
|
|
|
856,433 |
|
|
|
2018-07-09 |
13G
|
NSPR / InspireMD, Inc.
|
|
0 |
908,864 |
|
|
|
2018-07-06 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
4,360,500 |
4,360,500 |
|
|
|
2018-07-05 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
2,300,000 |
4,360,500 |
|
|
|
2018-07-02 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
3,634,316 |
|
|
|
2018-06-29 |
13G
|
CENN / Cenntro Inc.
|
|
|
2,370,516 |
|
|
|
2018-06-11 |
13G
|
PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock)
|
|
|
760,000 |
|
|
|
2018-05-17 |
13D/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
16,246,978 |
16,742,500 |
|
|
|
2018-04-23 |
13D
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
16,246,978 |
16,246,978 |
|
|
|
2018-04-20 |
13D
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
906,365 |
16,246,978 |
|
|
|
2018-04-18 |
13G/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
1,284,000 |
906,365 |
|
|
|
2018-04-09 |
13G
|
NSPR / InspireMD, Inc.
|
|
6,500 |
0 |
|
|
|
2018-04-05 |
13G
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
1,832,000 |
|
|
|
2018-03-30 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
1,836,000 |
|
|
|
2018-03-29 |
13G
|
APHB / Ampliphi Biosciences Corp.
|
|
|
0 |
|
|
|
2018-03-20 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
1,936,000 |
8,227,500 |
|
|
|
2018-03-19 |
13G
|
ATEC / Alphatec Holdings, Inc.
|
|
|
2,550,361 |
|
|
|
2018-03-12 |
13G
|
FRPT / Freshpet, Inc.
|
|
1,416,000 |
2,236,000 |
|
|
|
2018-02-20 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
|
1,607,500 |
|
|
|
2018-02-16 |
13G
|
ATRS / Antares Pharma Inc
|
|
7,600,000 |
10,000,000 |
|
|
|
2018-02-14 |
13G/A
|
DYNT / Dynatronics Corporation
|
|
500,000 |
814,670 |
|
|
|
2018-02-14 |
13G/A
|
CHEK / Check-Cap Ltd.
|
|
1,068,000 |
972,215 |
|
|
|
2018-02-14 |
13G/A
|
IPCI / Intellipharmaceutics International Inc.
|
|
1,816,000 |
1,936,000 |
|
|
|
2018-02-14 |
13G/A
|
ATNM / Actinium Pharmaceuticals, Inc.
|
|
4,000,000 |
4,464,000 |
|
|
|
2018-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,292,000 |
2,678,000 |
|
|
|
2018-02-14 |
13G/A
|
SEEL / Seelos Therapeutics, Inc.
|
|
1,450,000 |
850,000 |
|
|
|
2018-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
11,000,000 |
7,600,000 |
|
|
|
2018-02-14 |
13G/A
|
TMBR / Timber Pharmaceuticals Inc
|
|
6,670,000 |
6,514,623 |
|
|
|
2018-02-14 |
13G/A
|
ZSAN / Zosano Pharma Corp
|
|
1,200,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
1,614,000 |
1,284,000 |
|
|
|
2018-02-14 |
13G/A
|
AYTU / Aytu BioPharma, Inc.
|
|
8,112,818 |
502,881 |
|
|
|
2018-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
2,180,000 |
3,450,000 |
|
|
|
2018-02-14 |
13G/A
|
SBBP / Strongbridge Biopharma plc
|
|
1,796,000 |
2,870,000 |
|
|
|
2018-02-14 |
13G/A
|
ASRT / Assertio Holdings, Inc.
|
|
4,050,000 |
3,658,000 |
|
|
|
2018-02-14 |
13G/A
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
1,852,000 |
1,856,000 |
|
|
|
2018-02-14 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,144,000 |
0 |
|
|
|
2018-02-12 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
6,936,000 |
6,936,000 |
|
|
|
2018-02-12 |
13G
|
OPGN / OpGen, Inc.
|
|
|
358,505 |
|
|
|
2018-02-09 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
3,358,000 |
6,936,000 |
|
|
|
2018-01-29 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
2,300,000 |
2,300,000 |
|
|
|
2018-01-26 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
2,000,000 |
2,300,000 |
|
|
|
2018-01-18 |
13G
|
APRN / Blue Apron Holdings Inc - Class A
|
|
|
2,650,000 |
|
|
|
2017-12-04 |
13G
|
IPCI / Intellipharmaceutics International Inc.
|
|
1,636,000 |
1,816,000 |
|
|
|
2017-11-30 |
13G
|
TMBR / Timber Pharmaceuticals Inc
|
|
|
6,670,000 |
|
|
|
2017-11-30 |
13G
|
CHEK / Check-Cap Ltd.
|
|
|
1,068,000 |
|
|
|
2017-11-24 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
30,155,584 |
30,335,714 |
|
|
|
2017-11-20 |
13G
|
BBI / Brickell Biotech Inc
|
|
|
2,000,000 |
|
|
|
2017-11-03 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
768,915 |
|
|
|
2017-10-23 |
13G
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
531,354 |
|
|
|
2017-10-20 |
13G
|
IPCI / Intellipharmaceutics International Inc.
|
|
|
1,636,000 |
|
|
|
2017-09-22 |
13G
|
SBBP / Strongbridge Biopharma plc
|
|
|
1,796,000 |
|
|
|
2017-09-20 |
13G
|
SEEL / Seelos Therapeutics, Inc.
|
|
|
1,450,000 |
|
|
|
2017-08-30 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
29,609,938 |
30,155,584 |
|
|
|
2017-08-24 |
13G
|
AYTU / Aytu BioPharma, Inc.
|
|
|
8,112,818 |
|
|
|
2017-08-18 |
13G
|
ASRT / Assertio Holdings, Inc.
|
|
|
4,050,000 |
|
|
|
2017-08-04 |
13G
|
ATNM / Actinium Pharmaceuticals, Inc.
|
|
|
4,000,000 |
|
|
|
2017-07-11 |
13G
|
OCGN / Ocugen, Inc.
|
|
|
1,333,333 |
|
|
|
2017-07-06 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
29,609,938 |
29,609,938 |
|
|
|
2017-07-05 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
3,360,000 |
29,609,938 |
|
|
|
2017-06-23 |
13G
|
IDXG / Interpace Biosciences, Inc.
|
|
|
965,784 |
|
|
|
2017-06-19 |
13G
|
KPRX / Kiora Pharmaceuticals, Inc.
|
|
|
1,614,000 |
|
|
|
2017-06-19 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
1,630,000 |
2,292,000 |
|
|
|
2017-06-12 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
2,180,000 |
|
|
|
2017-06-01 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
1,144,000 |
|
|
|
2017-05-24 |
13G
|
DYNT / Dynatronics Corporation
|
|
|
500,000 |
|
|
|
2017-05-23 |
13G
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
1,852,000 |
|
|
|
2017-05-16 |
13D/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
3,210,000 |
3,360,000 |
|
|
|
2017-05-08 |
13D
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
3,210,000 |
|
|
|
2017-02-14 |
13G/A
|
85172J101 / Springleaf Holdings, Inc.
|
|
|
0 |
|
|
|
2017-02-14 |
13G/A
|
FRPT / Freshpet, Inc.
|
|
1,694,000 |
1,416,000 |
|
|
|
2017-02-14 |
13G/A
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
3,799,549 |
0 |
|
|
|
2017-02-14 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
13,240,000 |
11,000,000 |
|
|
|
2017-02-14 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
1,664,000 |
0 |
|
|
|
2017-02-14 |
13G/A
|
ZSAN / Zosano Pharma Corp
|
|
1,024,000 |
1,200,000 |
|
|
|
2017-02-14 |
13G/A
|
45779A119 / InspireMD, Inc. Warrants
|
|
0 |
6,500 |
|
|
|
2017-02-14 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
3,132,000 |
0 |
|
|
|
2017-02-14 |
13G/A
|
DMD / Demand Media Inc.
|
|
1,156,000 |
0 |
|
|
|
2017-02-14 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
1,744,000 |
2,000,000 |
|
|
|
2017-01-19 |
13G
|
ALIM / Alimera Sciences, Inc.
|
|
|
3,358,000 |
|
|
|
2016-11-16 |
13G
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
1,664,000 |
1,664,000 |
|
|
|
2016-11-15 |
13G
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
1,502,000 |
1,664,000 |
|
|
|
2016-10-17 |
13G
|
ZSAN / Zosano Pharma Corp
|
|
|
1,024,000 |
|
|
|
2016-03-24 |
13G
|
451731103 / Ignyta, Inc.
|
|
952,000 |
1,744,000 |
|
|
|
2016-03-07 |
13G
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
1,502,000 |
|
|
|
2016-02-16 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
|
952,000 |
|
|
|
2016-02-16 |
13G/A
|
NSPR / InspireMD, Inc.
|
|
6,700,000 |
0 |
|
|
|
2016-02-16 |
13G/A
|
FRPT / Freshpet, Inc.
|
|
2,024,000 |
1,694,000 |
|
|
|
2016-02-16 |
13G/A
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
31,425,000 |
3,799,549 |
|
|
|
2016-02-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
DMD / Demand Media Inc.
|
|
1,032,000 |
1,156,000 |
|
|
|
2016-02-16 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,280,000 |
1,630,000 |
|
|
|
2016-02-16 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
3,400,000 |
0 |
|
|
|
2016-02-16 |
13G/A
|
ATRS / Antares Pharma Inc
|
|
8,060,000 |
13,240,000 |
|
|
|
2016-01-21 |
13G
|
BDSI / Biodelivery Sciences International
|
|
|
3,132,000 |
|
|
|
2015-11-23 |
13G
|
FRPT / Freshpet, Inc.
|
|
|
2,024,000 |
|
|
|
2015-10-06 |
13G
|
XNPT / XenoPort, Inc.
|
|
|
2,600,000 |
|
|
|
2015-09-10 |
13G
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
|
31,425,000 |
|
|
|
2015-09-02 |
13G
|
ATRS / Antares Pharma Inc
|
|
|
8,060,000 |
|
|
|
2015-09-02 |
13D/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
4,424,000 |
991,010 |
|
|
|
2015-08-31 |
13G
|
DMD / Demand Media Inc.
|
|
|
1,032,000 |
|
|
|
2015-07-02 |
13G
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
3,400,000 |
|
|
|
2015-06-03 |
13D/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
3,600,000 |
4,424,000 |
|
|
|
2015-05-12 |
13D
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
|
3,600,000 |
|
|
|
2015-03-27 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
2,280,000 |
|
|
|
2015-03-16 |
13G
|
NSPR / InspireMD, Inc.
|
|
|
6,700,000 |
|
|
|
2015-02-17 |
13G/A
|
LPDX / Liposcience Inc
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
RLOC / ReachLocal, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
US0909311062 / BioSpecifics Technologies Corp.
|
|
|
105,000 |
|
|
|
2015-02-17 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
|
1,513,100 |
|
|
|
2015-02-17 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
9,400,000 |
|
|
|
2014-10-14 |
13G
|
RLOC / ReachLocal, Inc.
|
|
|
1,698,000 |
|
|
|
2014-08-25 |
13G
|
ZGNX / Zogenix Inc
|
|
|
8,300,000 |
|
|
|
2014-05-30 |
13G
|
DCIN / Digital Cinema Destinations Corp.
|
|
|
416,000 |
|
|
|
2014-04-24 |
13G
|
451731103 / Ignyta, Inc.
|
|
|
990,000 |
|
|
|
2014-03-20 |
13G
|
LPDX / Liposcience Inc
|
|
|
786,000 |
|
|
|